ERK5
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S444 | Sugiyama | SHTN1 KIAA1598 | RPVNQTARPKTKPESSKGCEsAVDELKGILGtLNKSTSSRs |
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00141 | S78 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SGK1 SGK | LKISQPQEPELMNANPsPPPsPsQQINLGPSSNPHAKPSDF |
| O00151 | S130 | Sugiyama | PDLIM1 CLIM1 CLP36 | PQEVLHIGsAHNRsAMPFtAsPAsSTTARVItNQyNNPAGL |
| O00151 | S133 | Sugiyama | PDLIM1 CLIM1 CLP36 | VLHIGsAHNRsAMPFtAsPAsSTTARVItNQyNNPAGLyss |
| O00410 | S974 | Sugiyama | IPO5 KPNB3 RANBP5 | VIQSADSKTKENVNAtENCIsAVGKIMKFKPDCVNVEEVLP |
| O14497 | S363 | Sugiyama | ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 | AAAAAAASGGAQQRsHHAPMsPGssGGGGQPLARtPQPssP |
| O14545 | S327 | Sugiyama | TRAFD1 FLN29 | DHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQQAAS |
| O14579 | S307 | Sugiyama | COPE | IKEYQAKENDFDRLVLQyAPsA___________________ |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14908 | S258 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | tGRGtLRLRsRGPAtVEDLPsAFEEKAIEKVDDLLESYMGI |
| O15143 | S336 | Sugiyama | ARPC1B ARC41 | AAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTTGMDGGMSI |
| O15230 | S422 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | GVNCERCLPGFYRSPNHPLDsPHVCRRCNCESDFTDGtCED |
| O43175 | S251 | Sugiyama | PHGDH PGDH3 | VVNCARGGIVDEGALLRALQsGQCAGAALDVFTEEPPRDRA |
| O43707 | T249 | Sugiyama | ACTN4 | EVAEKyLDIPKMLDAEDIVNtARPDEKAIMTyVssFyHAFs |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60361 | S107 | Sugiyama | NME2P1 | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDY |
| O60361 | S110 | Sugiyama | NME2P1 | RGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDYKSC |
| O60664 | S76 | Sugiyama | PLIN3 M6PRBP1 TIP47 | IKTVCDAAEKGVRtLTAAAVsGAQPILSKLEPQIAsAsEyA |
| O60664 | S91 | Sugiyama | PLIN3 M6PRBP1 TIP47 | TAAAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQ |
| O60664 | S93 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQP |
| O60664 | T69 | Sugiyama | PLIN3 M6PRBP1 TIP47 | TKESYPHIKTVCDAAEKGVRtLTAAAVsGAQPILSKLEPQI |
| O60749 | S119 | Sugiyama | SNX2 TRG9 | AVtPVtPttLIAPRIESKsMsAPVIFDRsREEIEEEANGDI |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O95067 | S392 | Sugiyama | CCNB2 | KLLKISMIPQLNSKAVKDLAsPLIGRs______________ |
| O95218 | S65 | Sugiyama | ZRANB2 ZIS ZNF265 | MKAGGtEIGKtLAEKSRGLFsANDWQCKTCsNVNWARRsEC |
| O95757 | S587 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | RLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGKM |
| O95831 | S519 | Sugiyama | AIFM1 AIF PDCD8 | DSSLPTVGVFAKATAQDNPKsAtEQsGtGIRSESETESEAS |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | S237 | Sugiyama | LDHA PIG19 | DLGtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVA |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00338 | T95 | Sugiyama | LDHA PIG19 | PKIVSGKDyNVTANsKLVIItAGARQQEGEsRLNLVQRNVN |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P01100 | S32 | EPSD|PSP | FOS G0S7 | ASSSRCSSASPAGDSLSYyHsPADSFSSMGSPVNAQDFCTD |
| P01100 | T232 | EPSD|PSP | FOS G0S7 | FPEEMSVASLDLTGGLPEVAtPESEEAFTLPLLNDPEPKPS |
| P01106 | S77 | PSP | MYC BHLHE39 | PPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVTPFsL |
| P03973 | T78 | Sugiyama | SLPI WAP4 WFDC4 | PGKKRCCPDTCGIKCLDPVDtPNPTRRKPGKCPVTYGQCLM |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04181 | T39 | Sugiyama | OAT | HSSVASATSVATKKtVQGPPtSDDIFEREyKyGAHNyHPLP |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05787 | S404 | Sugiyama | KRT8 CYK8 | LDIEIATYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLS |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06744 | T224 | Sugiyama | GPI | SLFIIASKTFTTQEtITNAEtAKEWFLQAAKDPSAVAKHFV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07195 | T96 | Sugiyama | LDHB | PKIVADKDysVtANSKIVVVtAGVRQQEGEsRLNLVQRNVN |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07237 | S449 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | ANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKF |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | S880 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LKAQYKEKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPE |
| P07814 | T746 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | NETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P08174 | S106 | Sugiyama | CD55 CR DAF | QWSDIEEFCNRSCEVPtRLNsAsLKQPYITQNyFPVGtVVE |
| P08174 | T102 | Sugiyama | CD55 CR DAF | LKGSQWSDIEEFCNRSCEVPtRLNsAsLKQPYITQNyFPVG |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08195 | S403 | Sugiyama | SLC3A2 MDU1 | SDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYL |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09651 | Y366 | Sugiyama | HNRNPA1 HNRPA1 | QyFAKPRNQGGyGGssssssyGsGRRF______________ |
| P09972 | S65 | Sugiyama | ALDOC ALDC | sQIGVENtEENRRLYRQVLFsADDRVKKCIGGVIFFHETLY |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P10809 | S175 | Sugiyama | HSPD1 HSP60 | LKKQsKPVttPEEIAQVAtIsANGDKEIGNIIsDAMKKVGR |
| P10809 | S225 | Sugiyama | HSPD1 HSP60 | KtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVL |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P10809 | T164 | Sugiyama | HSPD1 HSP60 | VMLAVDAVIAELKKQsKPVttPEEIAQVAtIsANGDKEIGN |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T222 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFI |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P12268 | S159 | Sugiyama | IMPDH2 IMPD2 | FCGIPITDtGRMGSRLVGIIssRDIDFLKEEEHDCFLEEIM |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12277 | S163 | Sugiyama | CKB CKBB | PPHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAE |
| P13489 | S208 | Sugiyama | RNH1 PRI RNH | RVLCQGLKDSPCQLEALKLEsCGVTSDNCRDLCGIVAsKAS |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13667 | S383 | Sugiyama | PDIA4 ERP70 ERP72 | FQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHRKVS |
| P13798 | S185 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | VAEKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQ |
| P13929 | S14 | Sugiyama | ENO3 | _______MAMQKIFAREILDsRGNPtVEVDLHtAKGRFRAA |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P13929 | T26 | Sugiyama | ENO3 | IFAREILDsRGNPtVEVDLHtAKGRFRAAVPsGAstGIyEA |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S37 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | T41 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtL |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14921 | T38 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ETS1 EWSR2 | KVDLELFPsPDMECADVPLLtPSsKEMMSQALKATFSGFTK |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | S125 | Sugiyama | NME1 NDPKA NM23 | RGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDyTsC |
| P15559 | S82 | Sugiyama | NQO1 DIA4 NMOR1 | DPANFQYPAESVLAYKEGHLsPDIVAEQKKLEAADLVIFQF |
| P15880 | S206 | Sugiyama | RPS2 RPS4 | GRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDCytsA |
| P16278 | S433 | Sugiyama | GLB1 ELNR1 | YGFVLYRTTLPQDCSNPAPLssPLNGVHDRAyVAVDGIPQG |
| P17066 | T224 | Sugiyama | HSPA6 HSP70B' | GGTFDVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFM |
| P17302 | S255 | SIGNOR|iPTMNet | GJA1 GJAL | GVKDRVKGKSDPyHATsGALsPAKDCGsQKyAyFNGCssPt |
| P17302 | S282 | iPTMNet | GJA1 GJAL | sQKyAyFNGCssPtAPLsPMsPPGyKLVTGDRNNssCRNYN |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18754 | S125 | Sugiyama | RCC1 CHC1 | VEGSEMVPGKVELQEKVVQVsAGDsHtAALTDDGRVFLWGS |
| P18754 | T131 | Sugiyama | RCC1 CHC1 | VPGKVELQEKVVQVsAGDsHtAALTDDGRVFLWGSFRDNNG |
| P19793 | S260 | iPTMNet | RXRA NR2B1 | LAVEPKTETyVEANMGLNPssPNDPVtNICQAADKQLFTLV |
| P19793 | T82 | iPTMNet | RXRA NR2B1 | GPPFsVISSPMGPHSMsVPTtPTLGFSTGSPQLSSPMNPVS |
| P20073 | S393 | Sugiyama | ANXA7 ANX7 SNX OK/SW-cl.95 | FPQLRATMEAYSRMANRDLLsSVSREFSGYVESGLKTILQC |
| P21333 | S1459 | Sugiyama | FLNA FLN FLN1 | KVPVHDVTDASKVKCsGPGLsPGMVRANLPQsFQVDTSKAG |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22314 | S816 | Sugiyama | UBA1 A1S9T UBE1 | VPEFtPKsGVKIHVsDQELQsANAsVDDsRLEELKATLPsP |
| P22314 | T233 | Sugiyama | UBA1 A1S9T UBE1 | GEQPLSAMVSMVTKDNPGVVtCLDEARHGFESGDFVSFSEV |
| P22392 | S122 | Sugiyama | NME2 NM23B | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDy |
| P22392 | S125 | Sugiyama | NME2 NM23B | RGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDyKSC |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P23381 | S351 | Sugiyama | WARS1 IFI53 WARS WRS | KPALLHSTFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTK |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | T220 | Sugiyama | RPS3 OK/SW-cl.26 | PKKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPV |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | T75 | Sugiyama | EIF4B | WHsNDDDVYRAPPIDRsILPtAPRAAREPNIDRSRLPKsPP |
| P24534 | S8 | Sugiyama | EEF1B2 EEF1B EF1B | _____________MGFGDLKsPAGLQVLNDyLADKSYIEGY |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P25815 | S47 | Sugiyama | S100P S100E | tLTKGELKVLMEKELPGFLQsGKDKDAVDKLLKDLDANGDA |
| P26232 | S667 | Sugiyama | CTNNA2 CAPR | YDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEEKAKIAEQV |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26640 | T47 | Sugiyama | VARS1 G7A VARS VARS2 | AGEGPGWGGAHPRICLQPPPtSRTPFPPPRLPALEQGPGGL |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P28074 | S175 | Sugiyama | PSMB5 LMPX MB1 X | SMGTMICGWDKRGPGLyyVDsEGNRISGATFSVGSGSVYAY |
| P29144 | S93 | Sugiyama | TPP2 | SGDVNTATEVEPKDGEIVGLsGRVLKIPASWTNPSGKYHIG |
| P29401 | S548 | Sugiyama | TKT | NIRVLDPFTIKPLDRKLILDsARAtKGRILTVEDHYYEGGI |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29590 | S403 | EPSD|PSP | PML MYL PP8675 RNF71 TRIM19 | LQDLSSCITQGKDAAVSKKAsPEAAstPRDPIDVDLPEEAE |
| P29590 | T409 | EPSD|PSP | PML MYL PP8675 RNF71 TRIM19 | CITQGKDAAVSKKAsPEAAstPRDPIDVDLPEEAERVKAQV |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S65 | Sugiyama | EEF1D EF1D | VILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRIA |
| P29692 | S74 | Sugiyama | EEF1D EF1D | RENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQsL |
| P29692 | T73 | Sugiyama | EEF1D EF1D | ARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQs |
| P29966 | S26 | Sugiyama | MARCKS MACS PRKCSL | SKTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAs |
| P30041 | T44 | Sugiyama | PRDX6 AOP2 KIAA0106 | RFHDFLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKR |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | S165 | Sugiyama | RPL12 | GRHPHDIIDDINsGAVECPAs____________________ |
| P30050 | S26 | Sugiyama | RPL12 | DPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDDI |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30101 | S443 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLN |
| P31153 | S247 | Sugiyama | MAT2A AMS2 MATA2 | IKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLtGRKII |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31327 | T536 | Sugiyama | CPS1 | CGVELFKRGVLKEYGVKVLGtsVEsIMATEDRQLFSDKLNE |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31943 | T100 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | HRyVEVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P31943 | T107 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | KSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSKEEI |
| P31948 | S459 | Sugiyama | STIP1 | EAMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRH |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P33316 | S164 | Sugiyama | DUT | YTIPPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDV |
| P34897 | T432 | Sugiyama | SHMT2 | CPGDRsAItPGGLRLGAPALtSRQFREDDFRRVVDFIDEGV |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T224 | Sugiyama | HSPA1L | GGTFDVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFV |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35221 | S668 | Sugiyama | CTNNA1 | FDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEQKAKIAEQV |
| P35606 | S160 | Sugiyama | COPB2 | GHTHYVMQIVINPKDNNQFAsAsLDRtIKVWQLGsssPNFT |
| P35606 | T828 | Sugiyama | COPB2 | EEWVKETHADLWPAKQyPLVtPNEERNVMEEGKDFQPSRst |
| P35613 | S277 | Sugiyama | BSG UNQ6505/PRO21383 | KITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPG |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35637 | S346 | Sugiyama | FUS TLS | TDRETGKLKGEAtVsFDDPPsAKAAIDWFDGKEFsGNPIKV |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38919 | S62 | Sugiyama | EIF4A3 DDX48 KIAA0111 | TMGLREDLLRGIyAyGFEKPsAIQQRAIKQIIKGRDVIAQS |
| P40227 | S49 | Sugiyama | CCT6A CCT6 CCTZ | GLQDVLRTNLGPKGTMKMLVsGAGDIKLTKDGNVLLHEMQI |
| P40763 | S701 | Sugiyama | STAT3 APRF | EAFGKyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNt |
| P46060 | S453 | Sugiyama | RANGAP1 KIAA1835 SD | DVstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAF |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S403 | Sugiyama | YAP1 YAP65 | DPFLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEM |
| P47756 | S90 | Sugiyama | CAPZB | SyRsPWSNKyDPPLEDGAMPsARLRKLEVEANNAFDQYRDL |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P48741 | T224 | Sugiyama | HSPA7 HSP70B | GGTFDVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFM |
| P49321 | S659 | Sugiyama | NASP | IEELKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsst |
| P49327 | S2039 | Sugiyama | FASN FAS | FSSVSCGRGNAGQsNyGFANsAMERICEKRRHEGLPGLAVQ |
| P50542 | S317 | Sugiyama | PEX5 PXR1 | EMAKRDAEAHPWLSDyDDLtsATyDKGYQFEEENPLRDHPQ |
| P50542 | T316 | Sugiyama | PEX5 PXR1 | EEMAKRDAEAHPWLSDyDDLtsATyDKGYQFEEENPLRDHP |
| P50991 | S166 | Sugiyama | CCT4 CCTD SRB | EILTDMSRPVELSDRETLLNsATTSLNSKVVSQYSSLLsPM |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P52594 | S368 | Sugiyama | AGFG1 HRB RAB RIP | GFGTTGKAPVGsVVsVPsQssAssDKYAALAELDSVFSSAA |
| P52597 | S107 | Sugiyama | HNRNPF HNRPF | KSHRTEMDWVLKHsGPNsADsANDGFVRLRGLPFGCTKEEI |
| P52888 | S29 | Sugiyama | THOP1 | GDMADAAsPCSVVNDLRWDLsAQQIEERTRELIEQTKRVyD |
| P53365 | S260 | Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53999 | S57 | Sugiyama | SUB1 PC4 RPO2TC1 | VKKQKTGETsRALsssKQssssRDDNMFQIGKMRYVSVRDF |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T225 | Sugiyama | HSPA2 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLA |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55072 | T14 | Sugiyama | VCP HEL-220 HEL-S-70 | _______MAsGADsKGDDLstAILKQKNRPNRLIVDEAINE |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P55795 | T100 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | HRyVEVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P55795 | T107 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | KSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSKEEI |
| P55809 | S509 | Sugiyama | OXCT1 OXCT SCOT | LWEGLTVDDVQKSTGCDFAVsPKLMPMQQIAN_________ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | S80 | Sugiyama | TPI1 TPI | IAVAAQNCyKVTNGAFtGEIsPGMIKDCGAtWVVLGHsERR |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T76 | Sugiyama | TPI1 TPI | LDPKIAVAAQNCyKVTNGAFtGEIsPGMIKDCGAtWVVLGH |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S233 | Sugiyama | ACTB | KEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVItIGNE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T229 | Sugiyama | ACTB | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60842 | S56 | Sugiyama | EIF4A1 DDX2A EIF4A | DMNLSESLLRGIyAyGFEKPsAIQQRAILPCIKGyDVIAQA |
| P60842 | S78 | Sugiyama | EIF4A1 DDX2A EIF4A | IQQRAILPCIKGyDVIAQAQsGtGKTATFAISILQQIELDL |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S238 | Sugiyama | RPS3A FTE1 MFTL | LKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyEP |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P62081 | S174 | Sugiyama | RPS7 | IKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T194 | Sugiyama | YWHAZ | FSVFYYEILNsPEKACSLAKtAFDEAIAELDtLsEEsyKDs |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S233 | Sugiyama | ACTG1 ACTG | KEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVItIGNE |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T229 | Sugiyama | ACTG1 ACTG | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78347 | S210 | Sugiyama | GTF2I BAP135 WBSCR6 | EPKKHVGGRVMVtDADRsILsPGGsCGPIKVKTEPTEDSGI |
| P78371 | S143 | Sugiyama | CCT2 99D8.1 CCTB | PQTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIA |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P78371 | T475 | Sugiyama | CCT2 99D8.1 CCTB | GYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGITE |
| P78417 | S13 | Sugiyama | GSTO1 GSTTLP28 | ________MSGESARsLGKGsAPPGPVPEGsIRIySMRFCP |
| P78527 | T2647 | Sugiyama | PRKDC HYRC HYRC1 | ARWPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPL |
| P78527 | T2649 | Sugiyama | PRKDC HYRC HYRC1 | WPVAGQIRAtQQQHDFtLtQtADGRssFDWLTGsstDPLVD |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| Q00610 | S886 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | IHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsRVVG |
| Q00613 | S307 | Sugiyama | HSF1 HSTF1 | RPLSSsPLVRVKEEPPsPPQsPRVEEAsPGRPssVDtLLsP |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00613 | T367 | Sugiyama | HSF1 HSTF1 | ALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNELSDH |
| Q00613 | T369 | Sugiyama | HSF1 HSTF1 | tDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLD |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01433 | S97 | Sugiyama | AMPD2 | FTRSLAESELRSAPYEFPEEsPIEQLEERRQRLERQISQDV |
| Q01518 | S431 | Sugiyama | CAP1 CAP | NKTDGCHAYLSKNSLDCEIVsAKSSEMNVLIPTEGGDFNEF |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q02078 | S355 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2A MEF2 | AYNTDYSLTSADLSALQGFNsPGMLSLGQVSAWQQHHLGQA |
| Q02078 | T312 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2A MEF2 | EELELNTQRISSSQATQPLAtPVVSVTtPSLPPQGLVYSAM |
| Q02078 | T319 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MEF2A MEF2 | QRISSSQATQPLAtPVVSVTtPSLPPQGLVYSAMPTAYNTD |
| Q02790 | S15 | Sugiyama | FKBP4 FKBP52 | ______MTAEEMKAtEsGAQsAPLPMEGVDIsPKQDEGVLK |
| Q02952 | S364 | Sugiyama | AKAP12 AKAP250 | EVAsEKLtAsEQAHPQEPAEsAHEPRLsAEyEKVELPsEEQ |
| Q04637 | S198 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | KTIRIRDPNQGGKDITEEIMsGARtAstPtPPQtGGGLEPQ |
| Q04721 | S838 | Sugiyama | NOTCH2 | TCHCVLPYTGKNCQTVLAPCsPNPCENAAVCKESPNFESYT |
| Q06413 | S387 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | MEF2C | GACTSTHLSQSSNLSLPSTQsLNIKSEPVsPPRDRTTtPSR |
| Q06413 | S419 | GPS6 | MEF2C | RDRTTtPSRYPQHTRHEAGRsPVDSLSSCSSSYDGSDREDH |
| Q09666 | S93 | Sugiyama | AHNAK PM227 | LLNTMGHHTVGLKLHRKGDRsPEPGQtWtREVFssCssEVV |
| Q12802 | S1294 | Sugiyama | AKAP13 BRX HT31 LBC | EACHMsLssPELGPLTKGLEsAFTEKVSTFPPGESLPMGST |
| Q12959 | S158 | EPSD|PSP | DLG1 | sEKNLsEIENVHGFVSHSHIsPIKPTEAVLPSPPTVPVIPV |
| Q13163 | S129 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAP2K5 MEK5 MKK5 PRKMK5 | CKPPGERNIHGLKVNtRAGPsQHssPAVsDsLPsNsLKKss |
| Q13163 | S137 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAP2K5 MEK5 MKK5 PRKMK5 | IHGLKVNtRAGPsQHssPAVsDsLPsNsLKKssAELKKILA |
| Q13163 | S142 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAP2K5 MEK5 MKK5 PRKMK5 | VNtRAGPsQHssPAVsDsLPsNsLKKssAELKKILANGQMN |
| Q13163 | S149 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | MAP2K5 MEK5 MKK5 PRKMK5 | sQHssPAVsDsLPsNsLKKssAELKKILANGQMNEQDIRYR |
| Q13164 | S14 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | _______MAEPLKEEDGEDGsAEPPGPVKAEPAHtAASVAA |
| Q13164 | S175 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | TLEHVRYFLYQLLRGLKyMHsAQVIHRDLKPSNLLVNENCE |
| Q13164 | S210 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | VNENCELKIGDFGMARGLCtsPAEHQYFMtEyVAtRWYRAP |
| Q13164 | S337 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | DRQALSLLGRMLRFEPSARIsAAAALRHPFLAKYHDPDDEP |
| Q13164 | S421 | EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | FQPSLQPVASEPGCPDVEMPsPWAPSGDCAMEsPPPAPPPC |
| Q13164 | S433 | EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | GCPDVEMPsPWAPSGDCAMEsPPPAPPPCPGPAPDTIDLTL |
| Q13164 | S496 | EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | KAALKAALLKSLRSRLRDGPsAPLEAPEPRKPVTAQERQRE |
| Q13164 | S567 | SIGNOR | MAPK7 BMK1 ERK5 PRKM7 | ASGGPStDPLAGLVLsDNDRsLLERWTRMARPAAPALTSVP |
| Q13164 | S731 | SIGNOR|EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | NLVTQQLSKsQVEDPLPPVFsGtPKGSGAGYGVGFDLEEFL |
| Q13164 | S770 | EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | FLNQsFDMGVADGPQDGQADsAsLsASLLADWLEGHGMNPA |
| Q13164 | S772 | EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | NQsFDMGVADGPQDGQADsAsLsASLLADWLEGHGMNPADI |
| Q13164 | S774 | EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | sFDMGVADGPQDGQADsAsLsASLLADWLEGHGMNPADIES |
| Q13164 | S803 | SIGNOR | MAPK7 BMK1 ERK5 PRKM7 | EGHGMNPADIESLQREIQMDsPMLLADLPDLQDP_______ |
| Q13164 | T209 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | LVNENCELKIGDFGMARGLCtsPAEHQYFMtEyVAtRWYRA |
| Q13164 | T219 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | GDFGMARGLCtsPAEHQYFMtEyVAtRWYRAPELMLSLHEY |
| Q13164 | T28 | EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | EDGEDGsAEPPGPVKAEPAHtAASVAAKNLALLKARSFDVT |
| Q13164 | T733 | SIGNOR|EPSD|PSP | MAPK7 BMK1 ERK5 PRKM7 | VTQQLSKsQVEDPLPPVFsGtPKGSGAGYGVGFDLEEFLNQ |
| Q13164 | T77 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | IIETIGNGAYGVVSSARRRLtGQQVAIKKIPNAFDVVTNAK |
| Q13164 | Y172 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | QPLTLEHVRYFLYQLLRGLKyMHsAQVIHRDLKPSNLLVNE |
| Q13164 | Y221 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | FGMARGLCtsPAEHQYFMtEyVAtRWYRAPELMLSLHEYTQ |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13573 | S224 | Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q13573 | S232 | Sugiyama | SNW1 SKIIP SKIP | FKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCIS |
| Q13610 | S65 | Sugiyama | PWP1 | EEGGGsDEEEtGsPsEDGMQsARTQARPREPLEDGDPEDDR |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14157 | S859 | Sugiyama | UBAP2L KIAA0144 NICE4 | FPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTL |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14240 | S57 | Sugiyama | EIF4A2 DDX2B EIF4F | DMNLKESLLRGIyAyGFEKPsAIQQRAIIPCIKGyDVIAQA |
| Q14240 | S79 | Sugiyama | EIF4A2 DDX2B EIF4F | IQQRAIIPCIKGyDVIAQAQsGtGKTATFAISILQQLEIEF |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14247 | S405 | Sugiyama | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | S438 | Sugiyama | CTTN EMS1 | sPVyEDAAsFKAELsyRGPVsGtEPEPVysMEAADyREASS |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14444 | T306 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEVVNS |
| Q14498 | S334 | Sugiyama | RBM39 HCC1 RNPC2 | FELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtT |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14814 | S180 | GPS6|SIGNOR|iPTMNet | MEF2D | SGSLVTPSLVTSSLTDPRLLsPQQPALQRNsVsPGLPQRPA |
| Q14934 | S168 | GPS6|EPSD | NFATC4 NFAT3 | PPEGFGGYREAGGQGGGAFFsPsPGSSSLSSWSFFSDASDE |
| Q14934 | S170 | GPS6|EPSD | NFATC4 NFAT3 | EGFGGYREAGGQGGGAFFsPsPGSSSLSSWSFFSDASDEAA |
| Q14980 | S1187 | Sugiyama | NUMA1 NMP22 NUMA | LQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQDHSKAED |
| Q14980 | S1757 | Sugiyama | NUMA1 NMP22 NUMA | ITSKLPRtQPDGtsVPGEPAsPIsQRLPPKVEsLEsLyFtP |
| Q15181 | S250 | Sugiyama | PPA1 IOPPP PP | LVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDALPPPC |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15773 | S238 | Sugiyama | MLF2 | GAGGRRAEGPPRLAIQGPEDsPsRQsRRYDW__________ |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16543 | T370 | Sugiyama | CDC37 CDC37A | EAKEGEEAGPGDPLLEAVPKtGDEKDVsV____________ |
| Q16630 | T404 | Sugiyama | CPSF6 CFIM68 | yGRPPPYDRGDyGPPGREMDtARtPLsEAEFEEIMNRNRAI |
| Q16719 | S460 | Sugiyama | KYNU | LyNsFHDVyKFTNLLtsILDsAETKN_______________ |
| Q16719 | T455 | Sugiyama | KYNU | VAPVPLyNsFHDVyKFTNLLtsILDsAETKN__________ |
| Q16762 | S202 | Sugiyama | TST | SRSQGRFLGTEPEPDAVGLDsGHIRGAVNMPFMDFLTEDGF |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q5JTZ9 | S466 | Sugiyama | AARS2 AARSL KIAA1270 | LGLPLDMVELMLEEKGVQLDsAGLERLAQEEAQHRARQAEP |
| Q5T4S7 | S178 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | AKLPQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLT |
| Q5T4S7 | S181 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PQTVKTLSDVEDQKELAsPVsPELRQKEVQMNFLNQLTSVF |
| Q5T5Y3 | S1152 | Sugiyama | CAMSAP1 | HLRPFPAssHPRtPtDPGLDsALEPSGDPHGKCLFDSYRLH |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | S933 | Sugiyama | POTEE A26C1A POTE2 | KEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVItIGNE |
| Q6S8J3 | T929 | Sugiyama | POTEE A26C1A POTE2 | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q86UE4 | S311 | Sugiyama | MTDH AEG1 LYRIC | VKLssQIsAGEEKWNsVsPAsAGKRKtEPSAWsQDtGDANt |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q8IWX8 | S822 | Sugiyama | CHERP DAN26 SCAF6 | SKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRLGEE |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8IYS1 | S27 | Sugiyama | PM20D2 ACY1L2 | RPVEGGACNGRSELELLKLRsAECIDEAAERLGALSRAIWS |
| Q8N1F7 | S112 | Sugiyama | NUP93 KIAA0095 | PVKDTDIQGFLKNEKDNALLsAIEESRKRtFGMAEEYHRES |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NBJ7 | S264 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | AAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPDsAsD |
| Q8NBJ7 | S281 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | ADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPPGEL |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8NBS9 | S129 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | MEDAKVYVAKVDCtAHsDVCsAQGVRGYPTLKLFKPGQEAV |
| Q8NBS9 | S255 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | EHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDGKKVD |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8TB72 | S82 | Sugiyama | PUM2 KIAA0235 PUMH2 | MVQRRsGQGFHGNsEVNAILsPRsEsGGLGVsMVEYVLsss |
| Q8TD19 | S29 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | RHCDsINSDFGSEsGGCGDssPGPSASQGPRAGGGAAEQEE |
| Q92530 | S152 | Sugiyama | PSMF1 | SRIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIP |
| Q92530 | T162 | Sugiyama | PSMF1 | IHEQWEKANVssPHREFPPAtAREVDPLRIPPHHPHTSRQP |
| Q92734 | S183 | Sugiyama | TFG | AsMsAFDPLKNQDEINKNVMsAFGLtDDQVsGPPsAPAEDR |
| Q92734 | S197 | Sugiyama | TFG | INKNVMsAFGLtDDQVsGPPsAPAEDRSGTPDSIASSSSAA |
| Q92804 | S295 | Sugiyama | TAF15 RBP56 TAF2N | TDKDTGKPKGEAtVsFDDPPsAKAAIDWFDGKEFHGNIIKV |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96F86 | S507 | Sugiyama | EDC3 LSM16 YJDC YJEFN2 PP844 | QEVGINYHSPFGCKFVIPLHsA___________________ |
| Q99460 | T830 | Sugiyama | PSMD1 | TFAYPAPLEVPKEKEKEKVStAVLsItAKAKKKEKEKEKKE |
| Q99460 | T836 | Sugiyama | PSMD1 | PLEVPKEKEKEKVStAVLsItAKAKKKEKEKEKKEEEKMEV |
| Q99497 | T154 | Sugiyama | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99613 | S639 | Sugiyama | EIF3C EIF3S8 | CAFRQGLTKDAHNALLDIQssGRAKELLGQGLLLRSLQERN |
| Q99733 | S53 | Sugiyama | NAP1L4 NAP2 | QNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQL |
| Q99733 | T51 | Sugiyama | NAP1L4 NAP2 | VMQNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALK |
| Q99759 | S145 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | RNHNsssPHSGVSRQVRIKAsQsAGDINtIyQPPEPRsRHL |
| Q99759 | S147 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | HNsssPHSGVSRQVRIKAsQsAGDINtIyQPPEPRsRHLsV |
| Q99759 | S166 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | QsAGDINtIyQPPEPRsRHLsVssQNPGRssPPPGYVPERQ |
| Q99759 | S176 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | QPPEPRsRHLsVssQNPGRssPPPGYVPERQQHIARQGSYT |
| Q99759 | S250 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | SLDRSADSPSFRKSRMSRAQsFPDNRQEysDREtQLYDKGV |
| Q99759 | S337 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | tNGENMGLAVQYLDPRGRLRsADsENALsVQERNVPTKsPs |
| Q99759 | S340 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | ENMGLAVQYLDPRGRLRsADsENALsVQERNVPTKsPsAPI |
| Q99759 | S345 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | AVQYLDPRGRLRsADsENALsVQERNVPTKsPsAPINWRRG |
| Q99759 | T153 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | HSGVSRQVRIKAsQsAGDINtIyQPPEPRsRHLsVssQNPG |
| Q99759 | T307 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | DYSDGRRtFPRIRRHQGNLFtLVPssRsLstNGENMGLAVQ |
| Q99759 | Y258 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | PSFRKSRMSRAQsFPDNRQEysDREtQLYDKGVKGGTYPRR |
| Q99816 | S232 | Sugiyama | TSG101 | TVGPSRDGtIsEDTIRAsLIsAVSDKLRWRMKEEMDRAQAE |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BS26 | S353 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | GDFKDVLIPGKLKQFVFDLHsGKLHREFHHGPDPTDTAPGE |
| Q9BUL5 | S124 | Sugiyama | PHF23 | AGPTQPGPPRSTFSRLQAPDsAtLLEKMKLKDSLFDLDGPK |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVP2 | S53 | Sugiyama | GNL3 E2IG3 NS | RKEAKKRGHKKPRKDPGVPNsAPFKEALLREAELRKQRLEE |
| Q9BXP5 | S493 | Sugiyama | SRRT ARS2 ASR2 | VNIKEICWNLQNIRLRECELsPGVNRDLTRRVRNINGITQH |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S437 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | HLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQGsQ |
| Q9C0C2 | S77 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | PSLLVPVGPRPPRGPLAELPsARKMNMLAGPQPYGGSKRPL |
| Q9H4A4 | S19 | Sugiyama | RNPEP APB | __MAsGEHsPGsGAARRPLHsAQAVDVAsAsNFRAFELLHL |
| Q9H4A4 | S27 | Sugiyama | RNPEP APB | sPGsGAARRPLHsAQAVDVAsAsNFRAFELLHLHLDLRAEF |
| Q9H6F5 | S80 | Sugiyama | CCDC86 CYCLON | ERPPKtsPGsPRLQQGAGLEsPQGQPEPGAAsPQRQQDLHL |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9P265 | T144 | Sugiyama | DIP2B KIAA1463 | PTKRRSTFVQsPADACtPPDtssAsEDEGsLRRQAALSAAL |
| Q9UHB6 | S490 | Sugiyama | LIMA1 EPLIN SREBP3 PP624 | ENEEILERPAQLANAREtPHsPGVEDAPIAKVGVLAAsMEA |
| Q9UJY1 | S27 | Sugiyama | HSPB8 CRYAC E2IG1 HSP22 PP1629 | PFSCHYPsRLRRDPFRDsPLsSRLLDDGFGMDPFPDDLTAS |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ35 | S2141 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sMsPtPLDRCRsPGMLEPLGssRtPMsVLQQAGGsMMDGPG |
| Q9UQ35 | S2272 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tAVNLADsRtPAAAAAMNLAsPRtAVAPsAVNLADPRtPtA |
| Q9UQ35 | S2453 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | QAPsQsLLPPAQDQPRsPVPsAFsDQsRCLIAQTTPVAGSQ |
| Q9Y266 | T303 | Sugiyama | NUDC | tRsMVEKMMYDQRQKsMGLPtsDEQKKQEILKKFMDQHPEM |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y2W1 | S219 | Sugiyama | THRAP3 BCLAF2 TRAP150 | DEAKEQtFsGGtsQDTKAsEssKPWPDAtyGtGsAsRAsAV |
| Q9Y2W1 | S243 | Sugiyama | THRAP3 BCLAF2 TRAP150 | WPDAtyGtGsAsRAsAVsELsPRERsPALKsPLQsVVVRRR |
| Q9Y2W2 | S237 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | RKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDDG |
| Q9Y3F4 | S228 | Sugiyama | STRAP MAWD UNRIP | FHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLy |
| Q9Y3P9 | T865 | Sugiyama | RABGAP1 HSPC094 | LQEANMRLEQENDDLAHELVtSKIALRKDLDNAEEKADALN |
| Q9Y4P8 | S413 | Sugiyama | WIPI2 CGI-50 | CPLVTQTYGAAAGKGTYVPssPtRLAYTDDLGAVGGACLED |
| Q9Y4P8 | T415 | Sugiyama | WIPI2 CGI-50 | LVTQTYGAAAGKGTYVPssPtRLAYTDDLGAVGGACLEDEA |
| Q9Y5M8 | S257 | Sugiyama | SRPRB PSEC0230 | LPLKVEFLECSAKGGRGDVGsADIQDLEKWLAKIA______ |
| Q9Y697 | S283 | Sugiyama | NFS1 NIFS HUSSY-08 | KGVGAIYIRRRPRVRVEALQsGGGQERGMRsGTVPTPLVVG |
| Q9Y6W5 | S442 | Sugiyama | WASF2 WAVE2 | DTTKPKSSLPAVSDARSDLLsAIRQGFQLRRVEEQREQEKR |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.296483e-08 | 7.887 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.247378e-08 | 7.140 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.515085e-06 | 5.258 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.613372e-06 | 5.251 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.791797e-06 | 5.009 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.042093e-05 | 4.982 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.033074e-05 | 4.986 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.381777e-05 | 4.860 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.381777e-05 | 4.860 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.906661e-05 | 4.720 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.653225e-05 | 4.576 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.653225e-05 | 4.576 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.752129e-05 | 4.560 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.614720e-05 | 4.442 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.521899e-05 | 4.453 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.614720e-05 | 4.442 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.674318e-05 | 4.330 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.872932e-05 | 4.312 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.149322e-05 | 4.211 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.266792e-05 | 4.203 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.059354e-05 | 4.218 | 1 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.245141e-05 | 4.034 | 1 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.021775e-05 | 4.096 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.802880e-05 | 4.167 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.021775e-05 | 4.096 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.487686e-05 | 4.126 | 1 | 0 |
| Heme signaling | R-HSA-9707616 | 8.949913e-05 | 4.048 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.021775e-05 | 4.096 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.681894e-05 | 4.175 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.211906e-04 | 3.917 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.883124e-04 | 3.725 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.883124e-04 | 3.725 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.875413e-04 | 3.541 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.102759e-04 | 3.508 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.050302e-04 | 3.516 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.259719e-04 | 3.487 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.373298e-04 | 3.472 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.409453e-04 | 3.467 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.083891e-04 | 3.389 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.165247e-04 | 3.380 | 1 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.185221e-04 | 3.378 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.764991e-04 | 3.322 | 1 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.488882e-04 | 3.261 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.473845e-04 | 3.262 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.686355e-04 | 3.245 | 1 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.692313e-04 | 3.245 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.141568e-04 | 3.212 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.721476e-04 | 3.173 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.570411e-04 | 3.182 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.698392e-04 | 3.174 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.861550e-04 | 3.164 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.700144e-04 | 3.114 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.410828e-04 | 3.075 | 1 | 1 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.054220e-04 | 3.094 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.054220e-04 | 3.094 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.778807e-04 | 3.109 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.200015e-04 | 3.036 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.583015e-04 | 3.018 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 9.913613e-04 | 3.004 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.164087e-03 | 2.934 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.094294e-03 | 2.679 | 1 | 0 |
| RET signaling | R-HSA-8853659 | 2.139835e-03 | 2.670 | 1 | 1 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.228048e-03 | 2.652 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.606983e-03 | 2.584 | 1 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.649106e-03 | 2.577 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.959490e-03 | 2.402 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.222489e-03 | 2.374 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.222489e-03 | 2.374 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.234811e-03 | 2.373 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.234811e-03 | 2.373 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.258213e-03 | 2.371 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.785998e-03 | 2.320 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.403945e-03 | 2.267 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.531567e-03 | 2.257 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.913476e-03 | 2.228 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.692653e-03 | 2.245 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.916767e-03 | 2.228 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.325273e-03 | 2.135 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 7.325273e-03 | 2.135 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.680686e-03 | 2.175 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.621915e-03 | 2.179 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.751731e-03 | 2.171 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.247071e-03 | 2.140 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.338123e-03 | 2.134 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.498906e-03 | 2.125 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.498906e-03 | 2.125 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.498906e-03 | 2.125 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.774055e-03 | 2.109 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.539281e-03 | 2.069 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.544628e-03 | 2.068 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.091609e-03 | 2.092 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.054122e-03 | 2.094 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.379295e-03 | 2.077 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.641476e-03 | 2.063 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 8.669290e-03 | 2.062 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.165606e-03 | 2.038 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.331540e-03 | 2.030 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.443132e-03 | 2.025 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.443132e-03 | 2.025 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.705625e-03 | 2.013 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 9.741978e-03 | 2.011 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.001251e-02 | 1.999 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.001251e-02 | 1.999 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.104884e-02 | 1.957 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.013794e-02 | 1.994 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.115947e-02 | 1.952 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.115947e-02 | 1.952 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.123028e-02 | 1.950 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.160030e-02 | 1.936 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.312290e-02 | 1.882 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.342360e-02 | 1.872 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.348285e-02 | 1.870 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.517718e-02 | 1.819 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.517718e-02 | 1.819 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.461187e-02 | 1.835 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.520825e-02 | 1.818 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.452261e-02 | 1.838 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.561425e-02 | 1.806 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.478400e-02 | 1.830 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.594217e-02 | 1.797 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.612996e-02 | 1.792 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.612996e-02 | 1.792 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.617414e-02 | 1.791 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.617414e-02 | 1.791 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.628439e-02 | 1.788 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.673047e-02 | 1.776 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.744126e-02 | 1.758 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.813549e-02 | 1.741 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.820569e-02 | 1.740 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.845303e-02 | 1.734 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.061653e-02 | 1.686 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.974059e-02 | 1.705 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.954960e-02 | 1.709 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.061653e-02 | 1.686 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.885083e-02 | 1.725 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.061653e-02 | 1.686 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.171936e-02 | 1.663 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.223499e-02 | 1.653 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.223499e-02 | 1.653 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.223499e-02 | 1.653 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.249904e-02 | 1.648 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.271166e-02 | 1.644 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.286958e-02 | 1.641 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.286958e-02 | 1.641 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.288777e-02 | 1.640 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.313052e-02 | 1.636 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.369768e-02 | 1.625 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.534380e-02 | 1.596 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.534380e-02 | 1.596 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.585399e-02 | 1.587 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.585399e-02 | 1.587 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.910628e-02 | 1.536 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.818944e-02 | 1.550 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.651681e-02 | 1.576 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.920313e-02 | 1.535 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.920313e-02 | 1.535 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.988097e-02 | 1.525 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.018260e-02 | 1.520 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.023876e-02 | 1.519 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.023876e-02 | 1.519 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.023876e-02 | 1.519 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.034926e-02 | 1.518 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.088569e-02 | 1.510 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.138958e-02 | 1.503 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.183944e-02 | 1.497 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.214569e-02 | 1.493 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.261781e-02 | 1.487 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.261781e-02 | 1.487 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.288685e-02 | 1.483 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.334250e-02 | 1.477 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.439289e-02 | 1.464 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.448793e-02 | 1.462 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.475629e-02 | 1.459 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.647160e-02 | 1.438 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.668439e-02 | 1.436 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.924225e-02 | 1.406 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.889917e-02 | 1.410 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.741629e-02 | 1.427 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.812557e-02 | 1.419 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.668439e-02 | 1.436 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.947032e-02 | 1.404 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.057305e-02 | 1.392 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.099558e-02 | 1.387 | 1 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.156502e-02 | 1.381 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.193698e-02 | 1.377 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.199855e-02 | 1.377 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.200877e-02 | 1.377 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.325183e-02 | 1.364 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.394213e-02 | 1.357 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.464575e-02 | 1.350 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.464575e-02 | 1.350 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.464575e-02 | 1.350 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.464575e-02 | 1.350 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.484179e-02 | 1.348 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.517037e-02 | 1.345 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.589883e-02 | 1.338 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.770908e-02 | 1.321 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.777603e-02 | 1.321 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.024208e-02 | 1.299 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.015291e-02 | 1.300 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.015291e-02 | 1.300 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.015291e-02 | 1.300 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.015291e-02 | 1.300 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.046929e-02 | 1.297 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.265022e-02 | 1.279 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.494000e-02 | 1.260 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.046929e-02 | 1.297 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.046929e-02 | 1.297 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.024208e-02 | 1.299 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.046929e-02 | 1.297 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.580853e-02 | 1.253 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.190823e-02 | 1.285 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.129926e-02 | 1.290 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.494000e-02 | 1.260 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.678987e-02 | 1.246 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.682121e-02 | 1.245 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.796467e-02 | 1.237 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.796467e-02 | 1.237 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.796467e-02 | 1.237 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.796467e-02 | 1.237 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.796467e-02 | 1.237 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.796467e-02 | 1.237 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.916333e-02 | 1.228 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.921844e-02 | 1.228 | 1 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.921844e-02 | 1.228 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.924286e-02 | 1.227 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.023079e-02 | 1.220 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.184043e-02 | 1.209 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.257397e-02 | 1.204 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.257397e-02 | 1.204 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.257397e-02 | 1.204 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.634173e-02 | 1.178 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.634173e-02 | 1.178 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.634173e-02 | 1.178 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.588556e-02 | 1.120 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.789068e-02 | 1.168 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.146476e-02 | 1.146 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.524913e-02 | 1.185 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.356848e-02 | 1.133 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.356848e-02 | 1.133 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.368171e-02 | 1.196 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.084690e-02 | 1.150 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.195912e-02 | 1.143 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.995394e-02 | 1.155 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.084690e-02 | 1.150 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.084690e-02 | 1.150 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.084690e-02 | 1.150 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.084690e-02 | 1.150 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.146476e-02 | 1.146 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.088825e-02 | 1.149 | 1 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.084690e-02 | 1.150 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.690925e-02 | 1.175 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.634173e-02 | 1.178 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.645865e-02 | 1.117 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.645865e-02 | 1.117 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.645865e-02 | 1.117 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.645865e-02 | 1.117 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.645865e-02 | 1.117 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.645865e-02 | 1.117 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.680912e-02 | 1.115 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.951238e-02 | 1.100 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 8.027706e-02 | 1.095 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.301110e-02 | 1.081 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.448913e-02 | 1.073 | 1 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.647657e-02 | 1.063 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.981200e-02 | 1.047 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.020485e-02 | 1.045 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 9.020485e-02 | 1.045 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 9.020485e-02 | 1.045 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.067306e-02 | 1.043 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.067306e-02 | 1.043 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.067306e-02 | 1.043 | 1 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 9.186342e-02 | 1.037 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 9.186342e-02 | 1.037 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.333389e-02 | 1.030 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.471425e-02 | 1.024 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 9.471425e-02 | 1.024 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.828288e-02 | 1.008 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.828288e-02 | 1.008 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 9.828288e-02 | 1.008 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.828288e-02 | 1.008 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.828288e-02 | 1.008 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.828288e-02 | 1.008 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.828288e-02 | 1.008 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.828288e-02 | 1.008 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.828288e-02 | 1.008 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.828288e-02 | 1.008 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.828288e-02 | 1.008 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.828288e-02 | 1.008 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 1.170801e-01 | 0.932 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.155107e-01 | 0.937 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.087327e-01 | 0.964 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.157356e-01 | 0.937 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.071700e-01 | 0.970 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.178654e-01 | 0.929 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.639444e-02 | 1.016 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.108356e-01 | 0.955 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.157356e-01 | 0.937 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 9.828288e-02 | 1.008 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.155107e-01 | 0.937 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.168619e-01 | 0.932 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.178654e-01 | 0.929 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.050449e-01 | 0.979 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.170801e-01 | 0.932 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.087327e-01 | 0.964 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.170801e-01 | 0.932 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.005437e-01 | 0.998 | 1 | 1 |
| Axon guidance | R-HSA-422475 | 9.875459e-02 | 1.005 | 1 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.828288e-02 | 1.008 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.051031e-01 | 0.978 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.051031e-01 | 0.978 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.058460e-01 | 0.975 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.187718e-01 | 0.925 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.091751e-01 | 0.962 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.102831e-01 | 0.957 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.188991e-01 | 0.925 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.188991e-01 | 0.925 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.188991e-01 | 0.925 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.192814e-01 | 0.923 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.192814e-01 | 0.923 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.200242e-01 | 0.921 | 0 | 0 |
| Defective Base Excision Repair Associated with NEIL1 | R-HSA-9616334 | 1.233036e-01 | 0.909 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.233036e-01 | 0.909 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.233036e-01 | 0.909 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.256809e-01 | 0.901 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.263947e-01 | 0.898 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.269908e-01 | 0.896 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.269908e-01 | 0.896 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.292105e-01 | 0.889 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.292105e-01 | 0.889 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.320061e-01 | 0.879 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.320061e-01 | 0.879 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.320061e-01 | 0.879 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.331702e-01 | 0.876 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.335797e-01 | 0.874 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.335797e-01 | 0.874 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.361837e-01 | 0.866 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.371701e-01 | 0.863 | 1 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.381048e-01 | 0.860 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.381048e-01 | 0.860 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.381048e-01 | 0.860 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.396143e-01 | 0.855 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.411208e-01 | 0.850 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.411208e-01 | 0.850 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.413104e-01 | 0.850 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.413104e-01 | 0.850 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.413104e-01 | 0.850 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.413104e-01 | 0.850 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.413104e-01 | 0.850 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 1.413104e-01 | 0.850 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.422085e-01 | 0.847 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.443153e-01 | 0.841 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.444780e-01 | 0.840 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.874397e-01 | 0.727 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.874397e-01 | 0.727 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.874397e-01 | 0.727 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.874397e-01 | 0.727 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.874397e-01 | 0.727 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.874397e-01 | 0.727 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.874397e-01 | 0.727 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.465162e-01 | 0.834 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.465162e-01 | 0.834 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.465162e-01 | 0.834 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.780467e-01 | 0.749 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.780467e-01 | 0.749 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.623035e-01 | 0.790 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.465450e-01 | 0.834 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.465450e-01 | 0.834 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.878983e-01 | 0.726 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.878983e-01 | 0.726 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.672888e-01 | 0.777 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.492980e-01 | 0.826 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.891045e-01 | 0.723 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.866726e-01 | 0.729 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.620667e-01 | 0.790 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.825196e-01 | 0.739 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.775212e-01 | 0.751 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.800687e-01 | 0.745 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.734913e-01 | 0.761 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.591960e-01 | 0.798 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.518943e-01 | 0.818 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.492980e-01 | 0.826 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.891045e-01 | 0.723 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.940517e-01 | 0.712 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.620667e-01 | 0.790 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.780467e-01 | 0.749 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.465450e-01 | 0.834 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.472712e-01 | 0.832 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.579143e-01 | 0.802 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.623035e-01 | 0.790 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.878983e-01 | 0.726 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.687045e-01 | 0.773 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.867985e-01 | 0.729 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.866726e-01 | 0.729 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.675449e-01 | 0.776 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.866726e-01 | 0.729 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.678012e-01 | 0.775 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.729789e-01 | 0.762 | 1 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.726161e-01 | 0.763 | 1 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.815690e-01 | 0.741 | 1 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.472712e-01 | 0.832 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.687045e-01 | 0.773 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.472712e-01 | 0.832 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.874397e-01 | 0.727 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.891045e-01 | 0.723 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.867985e-01 | 0.729 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.491071e-01 | 0.827 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.491071e-01 | 0.827 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.672888e-01 | 0.777 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.492980e-01 | 0.826 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.891045e-01 | 0.723 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.949971e-01 | 0.710 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.957592e-01 | 0.708 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.991800e-01 | 0.701 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.002990e-01 | 0.698 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.002990e-01 | 0.698 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.002990e-01 | 0.698 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.002990e-01 | 0.698 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.002990e-01 | 0.698 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.019998e-01 | 0.695 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.043880e-01 | 0.690 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.066002e-01 | 0.685 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.314096e-01 | 0.636 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.314096e-01 | 0.636 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.314096e-01 | 0.636 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.314096e-01 | 0.636 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.314096e-01 | 0.636 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.314096e-01 | 0.636 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.314096e-01 | 0.636 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.314096e-01 | 0.636 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.314096e-01 | 0.636 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.314096e-01 | 0.636 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.314096e-01 | 0.636 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.314096e-01 | 0.636 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.261906e-01 | 0.487 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.261906e-01 | 0.487 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.261906e-01 | 0.487 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 3.261906e-01 | 0.487 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.261906e-01 | 0.487 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.261906e-01 | 0.487 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.261906e-01 | 0.487 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.261906e-01 | 0.487 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.261906e-01 | 0.487 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.261906e-01 | 0.487 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.261906e-01 | 0.487 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.261906e-01 | 0.487 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.261906e-01 | 0.487 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.261906e-01 | 0.487 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.352525e-01 | 0.628 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.352525e-01 | 0.628 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.352525e-01 | 0.628 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.112105e-01 | 0.675 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.836329e-01 | 0.547 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.836329e-01 | 0.547 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 2.836329e-01 | 0.547 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.836329e-01 | 0.547 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.836329e-01 | 0.547 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.836329e-01 | 0.547 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.836329e-01 | 0.547 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.836329e-01 | 0.547 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.092881e-01 | 0.388 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 4.092881e-01 | 0.388 | 1 | 1 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 4.092881e-01 | 0.388 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 4.092881e-01 | 0.388 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 4.092881e-01 | 0.388 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 4.092881e-01 | 0.388 | 0 | 0 |
| Defective F8 sulfation at Y1699 | R-HSA-9674519 | 4.092881e-01 | 0.388 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.455665e-01 | 0.610 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.455665e-01 | 0.610 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.146726e-01 | 0.668 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.146726e-01 | 0.668 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.317145e-01 | 0.479 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.317145e-01 | 0.479 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.317145e-01 | 0.479 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.317145e-01 | 0.479 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 3.317145e-01 | 0.479 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.807030e-01 | 0.552 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.807030e-01 | 0.552 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.424072e-01 | 0.615 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.424072e-01 | 0.615 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.424072e-01 | 0.615 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.708852e-01 | 0.567 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.162442e-01 | 0.500 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 3.162442e-01 | 0.500 | 1 | 1 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.162442e-01 | 0.500 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.788356e-01 | 0.422 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.788356e-01 | 0.422 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.788356e-01 | 0.422 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 3.788356e-01 | 0.422 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 3.788356e-01 | 0.422 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.788356e-01 | 0.422 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.788356e-01 | 0.422 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.821419e-01 | 0.317 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.821419e-01 | 0.317 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.821419e-01 | 0.317 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.821419e-01 | 0.317 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.821419e-01 | 0.317 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.821419e-01 | 0.317 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.821419e-01 | 0.317 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.998963e-01 | 0.523 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.187159e-01 | 0.660 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.518531e-01 | 0.454 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.518531e-01 | 0.454 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.518531e-01 | 0.454 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.518531e-01 | 0.454 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.245022e-01 | 0.372 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.245022e-01 | 0.372 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.245022e-01 | 0.372 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.245022e-01 | 0.372 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.245022e-01 | 0.372 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.245022e-01 | 0.372 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.097430e-01 | 0.509 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.872332e-01 | 0.412 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.872332e-01 | 0.412 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.587269e-01 | 0.445 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.151437e-01 | 0.501 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.151437e-01 | 0.501 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.816543e-01 | 0.550 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.379934e-01 | 0.471 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.221276e-01 | 0.375 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.221276e-01 | 0.375 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.221276e-01 | 0.375 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.683566e-01 | 0.329 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.683566e-01 | 0.329 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.683566e-01 | 0.329 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.683566e-01 | 0.329 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.460142e-01 | 0.263 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.460142e-01 | 0.263 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.460142e-01 | 0.263 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 5.460142e-01 | 0.263 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.460142e-01 | 0.263 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.195207e-01 | 0.496 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.195207e-01 | 0.496 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.195207e-01 | 0.496 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.388079e-01 | 0.470 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.174483e-01 | 0.379 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.563184e-01 | 0.341 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.563184e-01 | 0.341 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.563184e-01 | 0.341 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.563184e-01 | 0.341 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.582599e-01 | 0.446 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.123309e-01 | 0.385 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.181448e-01 | 0.497 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.016798e-01 | 0.520 | 1 | 1 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.072201e-01 | 0.390 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.463787e-01 | 0.350 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.101512e-01 | 0.292 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.710767e-01 | 0.431 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.378281e-01 | 0.359 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.974490e-01 | 0.401 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.676975e-01 | 0.435 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.744956e-01 | 0.561 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.643502e-01 | 0.438 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.302481e-01 | 0.366 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.748461e-01 | 0.323 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.748461e-01 | 0.323 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.721217e-01 | 0.429 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.366836e-01 | 0.360 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.296227e-01 | 0.367 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.441815e-01 | 0.463 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.027380e-01 | 0.299 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.027380e-01 | 0.299 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.218960e-01 | 0.282 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.218960e-01 | 0.282 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.497271e-01 | 0.260 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.020118e-01 | 0.220 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 6.020118e-01 | 0.220 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.020118e-01 | 0.220 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.020118e-01 | 0.220 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.020118e-01 | 0.220 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.790051e-01 | 0.421 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.530182e-01 | 0.257 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.530182e-01 | 0.257 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.138177e-01 | 0.289 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.564232e-01 | 0.255 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.869959e-01 | 0.231 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.869959e-01 | 0.231 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 5.869959e-01 | 0.231 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.869959e-01 | 0.231 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.869959e-01 | 0.231 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.597904e-01 | 0.252 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.829012e-01 | 0.234 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.829012e-01 | 0.234 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.829012e-01 | 0.234 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.829012e-01 | 0.234 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.648818e-01 | 0.248 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.648818e-01 | 0.248 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.688969e-01 | 0.245 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.134086e-01 | 0.212 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.045827e-01 | 0.219 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.068327e-01 | 0.217 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.114808e-01 | 0.214 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.114808e-01 | 0.214 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.114808e-01 | 0.214 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.219245e-01 | 0.206 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 6.219245e-01 | 0.206 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.219245e-01 | 0.206 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.218281e-01 | 0.206 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.215745e-01 | 0.207 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.170690e-01 | 0.380 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 2.284762e-01 | 0.641 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.485093e-01 | 0.605 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.031759e-01 | 0.518 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.031759e-01 | 0.518 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.076430e-01 | 0.683 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.031759e-01 | 0.518 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.504044e-01 | 0.601 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.504044e-01 | 0.601 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.653680e-01 | 0.332 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.218960e-01 | 0.282 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.683796e-01 | 0.434 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.162442e-01 | 0.500 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.151437e-01 | 0.501 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.379934e-01 | 0.471 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.757861e-01 | 0.323 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.750128e-01 | 0.240 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.455665e-01 | 0.610 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.354449e-01 | 0.628 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.518531e-01 | 0.454 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.463787e-01 | 0.350 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.450891e-01 | 0.611 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.054393e-01 | 0.218 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.872332e-01 | 0.412 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.757861e-01 | 0.323 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.233875e-01 | 0.373 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.869959e-01 | 0.231 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.597904e-01 | 0.252 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.118667e-01 | 0.674 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.788356e-01 | 0.422 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.274267e-01 | 0.643 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.865029e-01 | 0.543 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.871002e-01 | 0.231 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.338408e-01 | 0.631 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.898116e-01 | 0.310 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.268051e-01 | 0.278 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.836329e-01 | 0.547 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.424072e-01 | 0.615 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.208445e-01 | 0.494 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.023665e-01 | 0.299 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.429362e-01 | 0.265 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.744094e-01 | 0.562 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.882704e-01 | 0.540 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.749961e-01 | 0.323 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.302481e-01 | 0.366 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.673431e-01 | 0.573 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.429362e-01 | 0.265 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.836329e-01 | 0.547 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.162442e-01 | 0.500 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.788356e-01 | 0.422 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.845158e-01 | 0.546 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.101512e-01 | 0.292 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.027380e-01 | 0.299 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.500375e-01 | 0.347 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.532212e-01 | 0.452 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.869959e-01 | 0.231 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.597904e-01 | 0.252 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.721857e-01 | 0.242 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.585230e-01 | 0.339 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.272422e-01 | 0.644 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.563184e-01 | 0.341 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.612202e-01 | 0.442 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.612202e-01 | 0.442 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.836329e-01 | 0.547 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.518531e-01 | 0.454 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.245022e-01 | 0.372 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.097430e-01 | 0.509 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.460142e-01 | 0.263 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.455693e-01 | 0.351 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.829012e-01 | 0.234 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.657257e-01 | 0.247 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.219245e-01 | 0.206 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.123309e-01 | 0.385 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.827876e-01 | 0.316 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.921039e-01 | 0.308 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 5.299577e-01 | 0.276 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.662321e-01 | 0.331 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.114808e-01 | 0.214 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.272422e-01 | 0.644 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.974632e-01 | 0.527 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.378281e-01 | 0.359 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.302481e-01 | 0.366 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.664532e-01 | 0.331 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.219245e-01 | 0.206 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.261149e-01 | 0.646 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.330337e-01 | 0.633 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.469425e-01 | 0.607 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.546602e-01 | 0.256 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.352525e-01 | 0.628 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.112105e-01 | 0.675 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.092881e-01 | 0.388 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.092881e-01 | 0.388 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.146726e-01 | 0.668 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.292397e-01 | 0.482 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.072201e-01 | 0.390 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.105508e-01 | 0.508 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 4.748461e-01 | 0.323 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.218960e-01 | 0.282 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.497271e-01 | 0.260 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 6.020118e-01 | 0.220 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 6.020118e-01 | 0.220 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.020118e-01 | 0.220 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.126732e-01 | 0.290 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.869959e-01 | 0.231 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.820664e-01 | 0.235 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.766987e-01 | 0.239 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.909021e-01 | 0.228 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.435716e-01 | 0.464 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.168383e-01 | 0.380 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.587269e-01 | 0.445 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.325851e-01 | 0.274 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.882608e-01 | 0.411 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.804693e-01 | 0.420 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.864289e-01 | 0.232 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.123309e-01 | 0.385 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.040028e-01 | 0.219 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.455665e-01 | 0.610 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.460142e-01 | 0.263 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.460142e-01 | 0.263 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.896238e-01 | 0.310 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 6.020118e-01 | 0.220 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 5.869959e-01 | 0.231 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.167912e-01 | 0.499 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.587269e-01 | 0.445 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.185195e-01 | 0.378 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.415453e-01 | 0.355 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.572074e-01 | 0.590 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.174483e-01 | 0.379 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.444464e-01 | 0.352 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.737884e-01 | 0.241 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.072201e-01 | 0.390 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.896238e-01 | 0.310 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.896238e-01 | 0.310 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.151118e-01 | 0.288 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.620316e-01 | 0.582 | 1 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.663609e-01 | 0.575 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.072201e-01 | 0.390 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.029510e-01 | 0.395 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.759547e-01 | 0.559 | 1 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.997007e-01 | 0.301 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.068327e-01 | 0.217 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.466914e-01 | 0.262 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.268051e-01 | 0.278 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.555181e-01 | 0.255 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.050625e-01 | 0.516 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.875594e-01 | 0.541 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.577758e-01 | 0.339 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.261906e-01 | 0.487 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.261906e-01 | 0.487 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 4.092881e-01 | 0.388 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.708852e-01 | 0.567 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.821419e-01 | 0.317 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.821419e-01 | 0.317 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.998963e-01 | 0.523 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.245022e-01 | 0.372 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.683566e-01 | 0.329 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.683566e-01 | 0.329 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.460142e-01 | 0.263 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.460142e-01 | 0.263 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.610126e-01 | 0.442 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.101512e-01 | 0.292 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.022470e-01 | 0.396 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.050625e-01 | 0.516 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.395015e-01 | 0.469 | 1 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.531263e-01 | 0.344 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.961506e-01 | 0.402 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 6.020118e-01 | 0.220 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.020118e-01 | 0.220 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.020118e-01 | 0.220 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.869959e-01 | 0.231 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.510747e-01 | 0.259 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.382886e-01 | 0.269 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.196463e-01 | 0.658 | 1 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.503820e-01 | 0.601 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.395015e-01 | 0.469 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.083237e-01 | 0.681 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.708852e-01 | 0.567 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.845158e-01 | 0.546 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.643502e-01 | 0.438 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 5.551084e-01 | 0.256 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.838568e-01 | 0.234 | 1 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 3.866669e-01 | 0.413 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.827876e-01 | 0.316 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.219245e-01 | 0.206 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.730164e-01 | 0.564 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.609392e-01 | 0.443 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.174483e-01 | 0.379 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.424072e-01 | 0.615 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.292397e-01 | 0.482 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.299018e-01 | 0.638 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.218281e-01 | 0.206 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.981645e-01 | 0.303 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.268051e-01 | 0.278 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.807030e-01 | 0.552 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.151437e-01 | 0.501 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.460142e-01 | 0.263 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.717840e-01 | 0.566 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.631824e-01 | 0.580 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.108514e-01 | 0.676 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.424072e-01 | 0.615 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.292397e-01 | 0.482 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.683566e-01 | 0.329 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.683566e-01 | 0.329 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.219245e-01 | 0.206 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.219245e-01 | 0.206 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.219245e-01 | 0.206 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.176930e-01 | 0.662 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.191358e-01 | 0.496 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.974490e-01 | 0.401 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.531263e-01 | 0.344 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.959492e-01 | 0.305 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.211356e-01 | 0.376 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.530182e-01 | 0.257 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.587269e-01 | 0.445 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.587269e-01 | 0.445 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.777449e-01 | 0.238 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.212609e-01 | 0.283 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.615121e-01 | 0.442 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.261906e-01 | 0.487 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.261906e-01 | 0.487 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.836329e-01 | 0.547 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.708852e-01 | 0.567 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.821419e-01 | 0.317 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.845158e-01 | 0.546 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.572074e-01 | 0.590 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.221276e-01 | 0.375 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.683566e-01 | 0.329 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.563184e-01 | 0.341 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.463787e-01 | 0.350 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.444464e-01 | 0.352 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.497271e-01 | 0.260 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.564232e-01 | 0.255 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.721857e-01 | 0.242 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.097430e-01 | 0.509 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.409935e-01 | 0.267 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.114808e-01 | 0.214 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.422311e-01 | 0.616 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.866669e-01 | 0.413 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.101512e-01 | 0.292 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.112105e-01 | 0.675 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.118667e-01 | 0.674 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.112105e-01 | 0.675 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.317145e-01 | 0.479 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.170690e-01 | 0.380 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.027380e-01 | 0.299 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.497271e-01 | 0.260 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.065942e-01 | 0.295 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.631824e-01 | 0.580 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.112105e-01 | 0.675 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.092881e-01 | 0.388 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.788356e-01 | 0.422 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.821419e-01 | 0.317 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.460142e-01 | 0.263 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.460142e-01 | 0.263 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.020118e-01 | 0.220 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.068327e-01 | 0.217 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.378281e-01 | 0.359 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.587269e-01 | 0.445 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.928656e-01 | 0.227 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.219245e-01 | 0.206 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.054393e-01 | 0.218 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 3.599586e-01 | 0.444 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.027380e-01 | 0.299 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.352525e-01 | 0.628 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.245022e-01 | 0.372 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.460142e-01 | 0.263 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.497271e-01 | 0.260 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.020118e-01 | 0.220 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.530182e-01 | 0.257 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.352587e-01 | 0.475 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.166953e-01 | 0.287 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.896238e-01 | 0.310 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.981645e-01 | 0.303 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.174483e-01 | 0.379 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.105299e-01 | 0.677 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.563184e-01 | 0.341 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.020118e-01 | 0.220 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.124128e-01 | 0.290 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.020118e-01 | 0.220 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.045827e-01 | 0.219 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.497271e-01 | 0.260 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.223301e-01 | 0.206 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.230483e-01 | 0.205 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.230483e-01 | 0.205 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.236692e-01 | 0.205 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.262066e-01 | 0.203 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.271757e-01 | 0.203 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.271757e-01 | 0.203 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.281748e-01 | 0.202 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.306026e-01 | 0.200 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.306796e-01 | 0.200 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.306796e-01 | 0.200 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.306796e-01 | 0.200 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.387149e-01 | 0.195 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.387149e-01 | 0.195 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.387149e-01 | 0.195 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.427626e-01 | 0.192 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.469505e-01 | 0.189 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.511051e-01 | 0.186 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.511051e-01 | 0.186 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.511051e-01 | 0.186 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.511051e-01 | 0.186 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.511051e-01 | 0.186 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.511051e-01 | 0.186 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.511051e-01 | 0.186 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.511051e-01 | 0.186 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.511051e-01 | 0.186 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.511051e-01 | 0.186 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.511051e-01 | 0.186 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.511051e-01 | 0.186 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.511051e-01 | 0.186 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.511051e-01 | 0.186 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 6.511051e-01 | 0.186 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.511051e-01 | 0.186 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.511051e-01 | 0.186 | 0 | 0 |
| Threonine catabolism | R-HSA-8849175 | 6.511051e-01 | 0.186 | 0 | 0 |
| Diseases of Base Excision Repair | R-HSA-9605308 | 6.511051e-01 | 0.186 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.511051e-01 | 0.186 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.511051e-01 | 0.186 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.511051e-01 | 0.186 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.511051e-01 | 0.186 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.535760e-01 | 0.185 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.535760e-01 | 0.185 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.535760e-01 | 0.185 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 6.545232e-01 | 0.184 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.545232e-01 | 0.184 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.545232e-01 | 0.184 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.545232e-01 | 0.184 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.546471e-01 | 0.184 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.546471e-01 | 0.184 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.573572e-01 | 0.182 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.625322e-01 | 0.179 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.645800e-01 | 0.177 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.645800e-01 | 0.177 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.658544e-01 | 0.177 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.669535e-01 | 0.176 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.669535e-01 | 0.176 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.669535e-01 | 0.176 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.669535e-01 | 0.176 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 6.678112e-01 | 0.175 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.734864e-01 | 0.172 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.741301e-01 | 0.171 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.741301e-01 | 0.171 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.755007e-01 | 0.170 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.755007e-01 | 0.170 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.755007e-01 | 0.170 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.835294e-01 | 0.165 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.835540e-01 | 0.165 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.848353e-01 | 0.164 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.848353e-01 | 0.164 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.848353e-01 | 0.164 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.848353e-01 | 0.164 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.848353e-01 | 0.164 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.848353e-01 | 0.164 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.858721e-01 | 0.164 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.861993e-01 | 0.164 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.863338e-01 | 0.163 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.889716e-01 | 0.162 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.890692e-01 | 0.162 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.890692e-01 | 0.162 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.890692e-01 | 0.162 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.890692e-01 | 0.162 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.903807e-01 | 0.161 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.941451e-01 | 0.159 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.941451e-01 | 0.159 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.941451e-01 | 0.159 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.941451e-01 | 0.159 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.941451e-01 | 0.159 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.941451e-01 | 0.159 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.941451e-01 | 0.159 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.941451e-01 | 0.159 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.941451e-01 | 0.159 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.941451e-01 | 0.159 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 6.941451e-01 | 0.159 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.941451e-01 | 0.159 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.941451e-01 | 0.159 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.941451e-01 | 0.159 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 6.941451e-01 | 0.159 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.964149e-01 | 0.157 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.964149e-01 | 0.157 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.964149e-01 | 0.157 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.977335e-01 | 0.156 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.025846e-01 | 0.153 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.060992e-01 | 0.151 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.121895e-01 | 0.147 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.121895e-01 | 0.147 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.121895e-01 | 0.147 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.129288e-01 | 0.147 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.129288e-01 | 0.147 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.129288e-01 | 0.147 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 7.129288e-01 | 0.147 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.129288e-01 | 0.147 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 7.129288e-01 | 0.147 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.129288e-01 | 0.147 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.129288e-01 | 0.147 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.129288e-01 | 0.147 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.129288e-01 | 0.147 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 7.129288e-01 | 0.147 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.129288e-01 | 0.147 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.133151e-01 | 0.147 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.152682e-01 | 0.146 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.163961e-01 | 0.145 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.163961e-01 | 0.145 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.163961e-01 | 0.145 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.190390e-01 | 0.143 | 1 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.250278e-01 | 0.140 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.290431e-01 | 0.137 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.318779e-01 | 0.136 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.318779e-01 | 0.136 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.318779e-01 | 0.136 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.318779e-01 | 0.136 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.318779e-01 | 0.136 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.318779e-01 | 0.136 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 7.318779e-01 | 0.136 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.318779e-01 | 0.136 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.318779e-01 | 0.136 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.318779e-01 | 0.136 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.318779e-01 | 0.136 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.318779e-01 | 0.136 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.318779e-01 | 0.136 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.318779e-01 | 0.136 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.318779e-01 | 0.136 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.318779e-01 | 0.136 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.334097e-01 | 0.135 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.339596e-01 | 0.134 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.339596e-01 | 0.134 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.339596e-01 | 0.134 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.353667e-01 | 0.133 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.359158e-01 | 0.133 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.364292e-01 | 0.133 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.364292e-01 | 0.133 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.369593e-01 | 0.133 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.388897e-01 | 0.131 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.388897e-01 | 0.131 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 7.388897e-01 | 0.131 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.393129e-01 | 0.131 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.441594e-01 | 0.128 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.444000e-01 | 0.128 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.444000e-01 | 0.128 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.460619e-01 | 0.127 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.475164e-01 | 0.126 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.500079e-01 | 0.125 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.533638e-01 | 0.123 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.533638e-01 | 0.123 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.544076e-01 | 0.122 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.544076e-01 | 0.122 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.544076e-01 | 0.122 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.544076e-01 | 0.122 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.545805e-01 | 0.122 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.591196e-01 | 0.120 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.591196e-01 | 0.120 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.591196e-01 | 0.120 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.606496e-01 | 0.119 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.614648e-01 | 0.118 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.625376e-01 | 0.118 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.628164e-01 | 0.118 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.628164e-01 | 0.118 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.628164e-01 | 0.118 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.628164e-01 | 0.118 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.649575e-01 | 0.116 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.649575e-01 | 0.116 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.649575e-01 | 0.116 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.649575e-01 | 0.116 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.649575e-01 | 0.116 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.649575e-01 | 0.116 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.649575e-01 | 0.116 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.649575e-01 | 0.116 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.649575e-01 | 0.116 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.649575e-01 | 0.116 | 0 | 0 |
| Calcitonin-like ligand receptors | R-HSA-419812 | 7.649575e-01 | 0.116 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.649575e-01 | 0.116 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.649575e-01 | 0.116 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.649575e-01 | 0.116 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.649575e-01 | 0.116 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.654432e-01 | 0.116 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.683996e-01 | 0.114 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.687421e-01 | 0.114 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.711434e-01 | 0.113 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.732063e-01 | 0.112 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.732063e-01 | 0.112 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.734374e-01 | 0.112 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.735696e-01 | 0.112 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.735696e-01 | 0.112 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.735696e-01 | 0.112 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.735696e-01 | 0.112 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.735696e-01 | 0.112 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.735696e-01 | 0.112 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.843543e-01 | 0.105 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.848158e-01 | 0.105 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.848158e-01 | 0.105 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.848158e-01 | 0.105 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.848158e-01 | 0.105 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.848158e-01 | 0.105 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.855195e-01 | 0.105 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.865027e-01 | 0.104 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.865027e-01 | 0.104 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.865027e-01 | 0.104 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.865027e-01 | 0.104 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.890328e-01 | 0.103 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.896830e-01 | 0.103 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.914877e-01 | 0.102 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.914877e-01 | 0.102 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.939576e-01 | 0.100 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.939576e-01 | 0.100 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.939576e-01 | 0.100 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.939576e-01 | 0.100 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.939576e-01 | 0.100 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.939576e-01 | 0.100 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.939576e-01 | 0.100 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.939576e-01 | 0.100 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.939576e-01 | 0.100 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.939576e-01 | 0.100 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.939576e-01 | 0.100 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.939576e-01 | 0.100 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.939576e-01 | 0.100 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.939576e-01 | 0.100 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 7.939576e-01 | 0.100 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.939576e-01 | 0.100 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.939576e-01 | 0.100 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.956535e-01 | 0.099 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.972776e-01 | 0.098 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.994289e-01 | 0.097 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.994441e-01 | 0.097 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.995099e-01 | 0.097 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.995099e-01 | 0.097 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.009724e-01 | 0.096 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.009724e-01 | 0.096 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.016882e-01 | 0.096 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.032868e-01 | 0.095 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.047748e-01 | 0.094 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.049990e-01 | 0.094 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.049990e-01 | 0.094 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.049990e-01 | 0.094 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.049990e-01 | 0.094 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.082087e-01 | 0.092 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.082087e-01 | 0.092 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.082087e-01 | 0.092 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.082087e-01 | 0.092 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.082087e-01 | 0.092 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.082087e-01 | 0.092 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.082087e-01 | 0.092 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.082087e-01 | 0.092 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.082087e-01 | 0.092 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.093327e-01 | 0.092 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.093327e-01 | 0.092 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.117466e-01 | 0.091 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.117466e-01 | 0.091 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.117466e-01 | 0.091 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.126169e-01 | 0.090 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.139904e-01 | 0.089 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.162155e-01 | 0.088 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.165735e-01 | 0.088 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.193811e-01 | 0.087 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.193811e-01 | 0.087 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.193811e-01 | 0.087 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.193811e-01 | 0.087 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.193811e-01 | 0.087 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.193811e-01 | 0.087 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.193811e-01 | 0.087 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.193811e-01 | 0.087 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.193811e-01 | 0.087 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.193811e-01 | 0.087 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.193811e-01 | 0.087 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.193811e-01 | 0.087 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.193811e-01 | 0.087 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.193811e-01 | 0.087 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.193811e-01 | 0.087 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.193811e-01 | 0.087 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.199961e-01 | 0.086 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.199961e-01 | 0.086 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.199961e-01 | 0.086 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.217621e-01 | 0.085 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.234793e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.234793e-01 | 0.084 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.234793e-01 | 0.084 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.234793e-01 | 0.084 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.234793e-01 | 0.084 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.234793e-01 | 0.084 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.234793e-01 | 0.084 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.234793e-01 | 0.084 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.237829e-01 | 0.084 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.237829e-01 | 0.084 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.237829e-01 | 0.084 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.237829e-01 | 0.084 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.251021e-01 | 0.083 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.251021e-01 | 0.083 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.251021e-01 | 0.083 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.282249e-01 | 0.082 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.294718e-01 | 0.081 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.344529e-01 | 0.079 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.368063e-01 | 0.077 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.369045e-01 | 0.077 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.369045e-01 | 0.077 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.369045e-01 | 0.077 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.369045e-01 | 0.077 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.382630e-01 | 0.077 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.382630e-01 | 0.077 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.403695e-01 | 0.076 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.403695e-01 | 0.076 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.403695e-01 | 0.076 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.403695e-01 | 0.076 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.410394e-01 | 0.075 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.416689e-01 | 0.075 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 8.416689e-01 | 0.075 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 8.416689e-01 | 0.075 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 8.416689e-01 | 0.075 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 8.416689e-01 | 0.075 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.416689e-01 | 0.075 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.416689e-01 | 0.075 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.416689e-01 | 0.075 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.416689e-01 | 0.075 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.416689e-01 | 0.075 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.416689e-01 | 0.075 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.416689e-01 | 0.075 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.449519e-01 | 0.073 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.449519e-01 | 0.073 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.461114e-01 | 0.073 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.508011e-01 | 0.070 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.517032e-01 | 0.070 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.525587e-01 | 0.069 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.533515e-01 | 0.069 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.538562e-01 | 0.069 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.557806e-01 | 0.068 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.557806e-01 | 0.068 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.557806e-01 | 0.068 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.557806e-01 | 0.068 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.557806e-01 | 0.068 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.557806e-01 | 0.068 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.609064e-01 | 0.065 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.611128e-01 | 0.065 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.612076e-01 | 0.065 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.612076e-01 | 0.065 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.612076e-01 | 0.065 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.612076e-01 | 0.065 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.612076e-01 | 0.065 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.612076e-01 | 0.065 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.612076e-01 | 0.065 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.612076e-01 | 0.065 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 8.612076e-01 | 0.065 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 8.612076e-01 | 0.065 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.619953e-01 | 0.064 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.641582e-01 | 0.063 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.641582e-01 | 0.063 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.641582e-01 | 0.063 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.641582e-01 | 0.063 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.649143e-01 | 0.063 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.649143e-01 | 0.063 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.649143e-01 | 0.063 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.649143e-01 | 0.063 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.678392e-01 | 0.062 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.684612e-01 | 0.061 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.685432e-01 | 0.061 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.691150e-01 | 0.061 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.698203e-01 | 0.061 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.698203e-01 | 0.061 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.698203e-01 | 0.061 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.700555e-01 | 0.060 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.732301e-01 | 0.059 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.752467e-01 | 0.058 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.752467e-01 | 0.058 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.756828e-01 | 0.058 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.767752e-01 | 0.057 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.777359e-01 | 0.057 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.783361e-01 | 0.056 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.783361e-01 | 0.056 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.783361e-01 | 0.056 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.783361e-01 | 0.056 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.783361e-01 | 0.056 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.783361e-01 | 0.056 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.783361e-01 | 0.056 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.783361e-01 | 0.056 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.783361e-01 | 0.056 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.783361e-01 | 0.056 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.783361e-01 | 0.056 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.783361e-01 | 0.056 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.816426e-01 | 0.055 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.824609e-01 | 0.054 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.825923e-01 | 0.054 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.825923e-01 | 0.054 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.825923e-01 | 0.054 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.825923e-01 | 0.054 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.835882e-01 | 0.054 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.848881e-01 | 0.053 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.862341e-01 | 0.052 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.862341e-01 | 0.052 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.863313e-01 | 0.052 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.863313e-01 | 0.052 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.863313e-01 | 0.052 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.864683e-01 | 0.052 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.887075e-01 | 0.051 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.895793e-01 | 0.051 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.896820e-01 | 0.051 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.911230e-01 | 0.050 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.933516e-01 | 0.049 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.933516e-01 | 0.049 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.933516e-01 | 0.049 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.933516e-01 | 0.049 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.934764e-01 | 0.049 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.938730e-01 | 0.049 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.941957e-01 | 0.049 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.941957e-01 | 0.049 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.941957e-01 | 0.049 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.941957e-01 | 0.049 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.941957e-01 | 0.049 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.941957e-01 | 0.049 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.946799e-01 | 0.048 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.951199e-01 | 0.048 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.961569e-01 | 0.048 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.961569e-01 | 0.048 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.961569e-01 | 0.048 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.970588e-01 | 0.047 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.022360e-01 | 0.045 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.023349e-01 | 0.045 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.029762e-01 | 0.044 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.041004e-01 | 0.044 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.047243e-01 | 0.043 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.047243e-01 | 0.043 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.047243e-01 | 0.043 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.047243e-01 | 0.043 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.047243e-01 | 0.043 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.052115e-01 | 0.043 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.052115e-01 | 0.043 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.052115e-01 | 0.043 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.052115e-01 | 0.043 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.052115e-01 | 0.043 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.058331e-01 | 0.043 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.060694e-01 | 0.043 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 9.065148e-01 | 0.043 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.065148e-01 | 0.043 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.065148e-01 | 0.043 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.065148e-01 | 0.043 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.065148e-01 | 0.043 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.065148e-01 | 0.043 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.065148e-01 | 0.043 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 9.065148e-01 | 0.043 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.065148e-01 | 0.043 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.065148e-01 | 0.043 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.065148e-01 | 0.043 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.065148e-01 | 0.043 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.065148e-01 | 0.043 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.089469e-01 | 0.041 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.095184e-01 | 0.041 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.100108e-01 | 0.041 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.100108e-01 | 0.041 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.106620e-01 | 0.041 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.107227e-01 | 0.041 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.129036e-01 | 0.040 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.135454e-01 | 0.039 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.142665e-01 | 0.039 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.142665e-01 | 0.039 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.142665e-01 | 0.039 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.142665e-01 | 0.039 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.142665e-01 | 0.039 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.172306e-01 | 0.038 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 9.180539e-01 | 0.037 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.180539e-01 | 0.037 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.180539e-01 | 0.037 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.180539e-01 | 0.037 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 9.180539e-01 | 0.037 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.180539e-01 | 0.037 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.180539e-01 | 0.037 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.186634e-01 | 0.037 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.186634e-01 | 0.037 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.186634e-01 | 0.037 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.187057e-01 | 0.037 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.212070e-01 | 0.036 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.212070e-01 | 0.036 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.229055e-01 | 0.035 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.229055e-01 | 0.035 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.229055e-01 | 0.035 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.229055e-01 | 0.035 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.241538e-01 | 0.034 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.265162e-01 | 0.033 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.281693e-01 | 0.032 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.281693e-01 | 0.032 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.281693e-01 | 0.032 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.281693e-01 | 0.032 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.281693e-01 | 0.032 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.281693e-01 | 0.032 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.281693e-01 | 0.032 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.281693e-01 | 0.032 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.282425e-01 | 0.032 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.282425e-01 | 0.032 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.282620e-01 | 0.032 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.301332e-01 | 0.031 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.307187e-01 | 0.031 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.307187e-01 | 0.031 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.307187e-01 | 0.031 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.307187e-01 | 0.031 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.333933e-01 | 0.030 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.336977e-01 | 0.030 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.338162e-01 | 0.030 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.346964e-01 | 0.029 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.370366e-01 | 0.028 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.370366e-01 | 0.028 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.370366e-01 | 0.028 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.370366e-01 | 0.028 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.370366e-01 | 0.028 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.370366e-01 | 0.028 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.370366e-01 | 0.028 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.370366e-01 | 0.028 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.370366e-01 | 0.028 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.370366e-01 | 0.028 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.370366e-01 | 0.028 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.377784e-01 | 0.028 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.377784e-01 | 0.028 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.377784e-01 | 0.028 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.388970e-01 | 0.027 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.398341e-01 | 0.027 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.406107e-01 | 0.027 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.406107e-01 | 0.027 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.406107e-01 | 0.027 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.409374e-01 | 0.026 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.426894e-01 | 0.026 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.441514e-01 | 0.025 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.441514e-01 | 0.025 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.441514e-01 | 0.025 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.448097e-01 | 0.025 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.448097e-01 | 0.025 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.448097e-01 | 0.025 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.448097e-01 | 0.025 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.448097e-01 | 0.025 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.448097e-01 | 0.025 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.448097e-01 | 0.025 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.448097e-01 | 0.025 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.460251e-01 | 0.024 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.460251e-01 | 0.024 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.460251e-01 | 0.024 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.461600e-01 | 0.024 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.465179e-01 | 0.024 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.468876e-01 | 0.024 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.468876e-01 | 0.024 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.498997e-01 | 0.022 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.506274e-01 | 0.022 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.509774e-01 | 0.022 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.509774e-01 | 0.022 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.509774e-01 | 0.022 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.512848e-01 | 0.022 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.516236e-01 | 0.022 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.516236e-01 | 0.022 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.516236e-01 | 0.022 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.516236e-01 | 0.022 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.516236e-01 | 0.022 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.521003e-01 | 0.021 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.548051e-01 | 0.020 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.548051e-01 | 0.020 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.548051e-01 | 0.020 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.555029e-01 | 0.020 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.555029e-01 | 0.020 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.560361e-01 | 0.020 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.572370e-01 | 0.019 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.575965e-01 | 0.019 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.575965e-01 | 0.019 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.575965e-01 | 0.019 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.575965e-01 | 0.019 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.575965e-01 | 0.019 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.575965e-01 | 0.019 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.575965e-01 | 0.019 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.575965e-01 | 0.019 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.576468e-01 | 0.019 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.586546e-01 | 0.018 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.586546e-01 | 0.018 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.586546e-01 | 0.018 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.596348e-01 | 0.018 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.596348e-01 | 0.018 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.596348e-01 | 0.018 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.597459e-01 | 0.018 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.597459e-01 | 0.018 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.599676e-01 | 0.018 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.602399e-01 | 0.018 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.605823e-01 | 0.017 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.628323e-01 | 0.016 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.628323e-01 | 0.016 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.628323e-01 | 0.016 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.628323e-01 | 0.016 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.628323e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.628323e-01 | 0.016 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.628323e-01 | 0.016 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.634043e-01 | 0.016 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.635313e-01 | 0.016 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.639209e-01 | 0.016 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.639445e-01 | 0.016 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.654590e-01 | 0.015 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.654590e-01 | 0.015 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.674219e-01 | 0.014 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.674219e-01 | 0.014 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.674219e-01 | 0.014 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.674219e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.674219e-01 | 0.014 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 9.677203e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.677203e-01 | 0.014 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.677203e-01 | 0.014 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.677203e-01 | 0.014 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.683275e-01 | 0.014 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.684560e-01 | 0.014 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.692503e-01 | 0.014 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.693140e-01 | 0.014 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.699703e-01 | 0.013 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.699703e-01 | 0.013 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.699703e-01 | 0.013 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.699703e-01 | 0.013 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.699703e-01 | 0.013 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.700114e-01 | 0.013 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.705536e-01 | 0.013 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.711137e-01 | 0.013 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.711137e-01 | 0.013 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.711137e-01 | 0.013 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.714450e-01 | 0.013 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.714450e-01 | 0.013 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.714450e-01 | 0.013 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.714450e-01 | 0.013 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.716886e-01 | 0.012 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.722516e-01 | 0.012 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.728191e-01 | 0.012 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.738927e-01 | 0.011 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.741182e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.741615e-01 | 0.011 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.741615e-01 | 0.011 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.741615e-01 | 0.011 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.741799e-01 | 0.011 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.748480e-01 | 0.011 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.749714e-01 | 0.011 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.749714e-01 | 0.011 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.749714e-01 | 0.011 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.749714e-01 | 0.011 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.749714e-01 | 0.011 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.752220e-01 | 0.011 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.754102e-01 | 0.011 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.768973e-01 | 0.010 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.768973e-01 | 0.010 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.768973e-01 | 0.010 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.768973e-01 | 0.010 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.777955e-01 | 0.010 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.780626e-01 | 0.010 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.780626e-01 | 0.010 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.780626e-01 | 0.010 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.781771e-01 | 0.010 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.790068e-01 | 0.009 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.793517e-01 | 0.009 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.793517e-01 | 0.009 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.793517e-01 | 0.009 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.793517e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.793517e-01 | 0.009 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.793517e-01 | 0.009 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.793517e-01 | 0.009 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.799046e-01 | 0.009 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.799046e-01 | 0.009 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.799046e-01 | 0.009 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.807721e-01 | 0.008 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.807721e-01 | 0.008 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.807721e-01 | 0.008 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.807721e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.807721e-01 | 0.008 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.815316e-01 | 0.008 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.815524e-01 | 0.008 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.815524e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.815524e-01 | 0.008 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.818466e-01 | 0.008 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.824348e-01 | 0.008 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.828752e-01 | 0.008 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.831471e-01 | 0.007 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.831471e-01 | 0.007 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.831471e-01 | 0.007 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.835246e-01 | 0.007 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.835246e-01 | 0.007 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.835246e-01 | 0.007 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.835246e-01 | 0.007 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.836078e-01 | 0.007 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.836083e-01 | 0.007 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.839599e-01 | 0.007 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.841106e-01 | 0.007 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.843400e-01 | 0.007 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.852056e-01 | 0.006 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 9.852289e-01 | 0.006 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.852289e-01 | 0.006 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.852289e-01 | 0.006 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.852289e-01 | 0.006 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.852913e-01 | 0.006 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.852913e-01 | 0.006 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.852913e-01 | 0.006 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.852913e-01 | 0.006 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.853964e-01 | 0.006 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.860303e-01 | 0.006 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.863859e-01 | 0.006 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.863859e-01 | 0.006 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.866758e-01 | 0.006 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.868730e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.868730e-01 | 0.006 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.870536e-01 | 0.006 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.870536e-01 | 0.006 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.870536e-01 | 0.006 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.870536e-01 | 0.006 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.870536e-01 | 0.006 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.870536e-01 | 0.006 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.874853e-01 | 0.005 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.877782e-01 | 0.005 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.878476e-01 | 0.005 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.879638e-01 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.879789e-01 | 0.005 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.882885e-01 | 0.005 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.882885e-01 | 0.005 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.882885e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.882885e-01 | 0.005 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.886530e-01 | 0.005 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.886530e-01 | 0.005 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.886530e-01 | 0.005 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.886530e-01 | 0.005 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.886824e-01 | 0.005 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.893466e-01 | 0.005 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.895547e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.895547e-01 | 0.005 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.896256e-01 | 0.005 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.897951e-01 | 0.004 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.898411e-01 | 0.004 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.900549e-01 | 0.004 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.900549e-01 | 0.004 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.900549e-01 | 0.004 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.902237e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.904026e-01 | 0.004 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.906869e-01 | 0.004 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.911674e-01 | 0.004 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.911943e-01 | 0.004 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.912837e-01 | 0.004 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.915978e-01 | 0.004 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.916989e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.916989e-01 | 0.004 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.916989e-01 | 0.004 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.916989e-01 | 0.004 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.920715e-01 | 0.003 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.923607e-01 | 0.003 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.923607e-01 | 0.003 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.923607e-01 | 0.003 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.923607e-01 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.923805e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.923805e-01 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.923855e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.926030e-01 | 0.003 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.926030e-01 | 0.003 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.928639e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.932963e-01 | 0.003 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.934106e-01 | 0.003 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.934106e-01 | 0.003 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.934106e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.935795e-01 | 0.003 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.935795e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.941315e-01 | 0.003 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.941320e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.941320e-01 | 0.003 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.942253e-01 | 0.003 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.942253e-01 | 0.003 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.942253e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.946184e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.947750e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.948078e-01 | 0.002 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.948078e-01 | 0.002 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.948572e-01 | 0.002 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.948572e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.948572e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.948665e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.953491e-01 | 0.002 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.954928e-01 | 0.002 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.954928e-01 | 0.002 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.954928e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.954928e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.954928e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.960472e-01 | 0.002 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.960499e-01 | 0.002 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.960499e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.960499e-01 | 0.002 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.960561e-01 | 0.002 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.960970e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.961913e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.963177e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.963177e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.964058e-01 | 0.002 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.965382e-01 | 0.002 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.967246e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.969612e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.969638e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.969905e-01 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.969905e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.973411e-01 | 0.001 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.973411e-01 | 0.001 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.974210e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.975513e-01 | 0.001 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.976980e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.976980e-01 | 0.001 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.977591e-01 | 0.001 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.979579e-01 | 0.001 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.979579e-01 | 0.001 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.979579e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.979579e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.981823e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.982979e-01 | 0.001 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.984317e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.984317e-01 | 0.001 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.984403e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.987264e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.987264e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.987264e-01 | 0.001 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.987324e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.987324e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.987956e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.989445e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.989465e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.990903e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.990903e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.992675e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.993455e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.993629e-01 | 0.000 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.993771e-01 | 0.000 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.993776e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.993778e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.995221e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.995456e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.995683e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.996678e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.996826e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.996977e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.997240e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.997243e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997627e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.997836e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.998228e-01 | 0.000 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.998350e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998476e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.998544e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.998725e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998754e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999032e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999046e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999061e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999142e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999154e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999248e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999328e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999328e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999383e-01 | 0.000 | 1 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999401e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999415e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999483e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999494e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999506e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999623e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999702e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999702e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999756e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999761e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999771e-01 | 0.000 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.999794e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999852e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999858e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999885e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999921e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999935e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999955e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999955e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999972e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999976e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999984e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999987e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999988e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999991e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999996e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999998e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999998e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999998e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 1 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 1 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | -0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.220446e-15 | 14.654 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.554312e-14 | 13.808 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.965095e-14 | 13.707 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.904788e-14 | 13.102 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.609646e-13 | 12.336 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.575651e-12 | 11.254 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.119971e-11 | 10.506 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.542814e-10 | 9.812 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.780943e-10 | 9.749 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 1.857334e-10 | 9.731 | 1 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.546537e-10 | 9.122 | 1 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.369094e-10 | 9.028 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.050868e-10 | 9.043 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.461219e-09 | 8.835 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.936123e-09 | 8.713 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.242784e-09 | 8.649 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.715733e-09 | 8.566 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.127748e-09 | 8.384 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.976613e-09 | 8.224 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.018179e-09 | 8.154 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.260371e-09 | 8.139 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.143016e-08 | 7.942 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.867451e-08 | 7.729 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.045554e-08 | 7.393 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.083546e-08 | 7.294 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.336121e-08 | 7.273 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.006001e-07 | 6.997 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.001559e-07 | 6.999 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.397283e-08 | 7.027 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.167769e-07 | 6.933 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.265934e-07 | 6.898 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.368527e-07 | 6.864 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.503022e-07 | 6.823 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.943626e-07 | 6.711 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.159191e-07 | 6.666 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.205405e-07 | 6.494 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.507054e-07 | 6.455 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.488604e-07 | 6.457 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.254476e-07 | 6.371 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.942416e-07 | 6.306 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.864694e-07 | 6.163 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.580752e-07 | 6.120 | 1 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 9.168648e-07 | 6.038 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.168648e-07 | 6.038 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.044365e-06 | 5.981 | 1 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.407461e-06 | 5.852 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.670228e-06 | 5.777 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.891702e-06 | 5.723 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.951398e-06 | 5.710 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.242515e-06 | 5.649 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.196196e-06 | 5.658 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.516367e-06 | 5.599 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.708516e-06 | 5.567 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.950353e-06 | 5.530 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.505934e-06 | 5.455 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.505934e-06 | 5.455 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.468929e-06 | 5.460 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.758433e-06 | 5.425 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.826465e-06 | 5.417 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.039657e-06 | 5.394 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.585969e-06 | 5.253 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.476303e-06 | 5.262 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.915849e-06 | 5.228 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.697798e-06 | 5.174 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.697798e-06 | 5.174 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.696790e-06 | 5.174 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.265407e-06 | 5.083 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.808576e-06 | 5.055 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.833656e-06 | 5.054 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.192037e-05 | 4.924 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.300960e-05 | 4.886 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.272796e-05 | 4.895 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.543472e-05 | 4.812 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.558474e-05 | 4.807 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.592236e-05 | 4.798 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.592236e-05 | 4.798 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.668096e-05 | 4.778 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.698985e-05 | 4.770 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.872276e-05 | 4.728 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.888668e-05 | 4.724 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.890926e-05 | 4.723 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.207802e-05 | 4.656 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.248980e-05 | 4.648 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.408910e-05 | 4.618 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.563823e-05 | 4.591 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.721650e-05 | 4.565 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.791868e-05 | 4.554 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.791868e-05 | 4.554 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.174292e-05 | 4.498 | 1 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.719019e-05 | 4.430 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.582359e-05 | 4.446 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.209838e-05 | 4.376 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.272359e-05 | 4.278 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.945165e-05 | 4.306 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.201723e-05 | 4.284 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.133193e-05 | 4.290 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.107366e-05 | 4.214 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.111793e-05 | 4.214 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.319186e-05 | 4.199 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.446720e-05 | 4.073 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.665465e-05 | 4.062 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.041281e-04 | 3.982 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.131647e-04 | 3.946 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.131647e-04 | 3.946 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.082078e-04 | 3.966 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.341366e-04 | 3.872 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.408153e-04 | 3.851 | 1 | 1 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.475091e-04 | 3.831 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.497205e-04 | 3.825 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.613877e-04 | 3.792 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.770003e-04 | 3.752 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.789048e-04 | 3.747 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.770003e-04 | 3.752 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.808926e-04 | 3.743 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.808926e-04 | 3.743 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.876999e-04 | 3.727 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.909685e-04 | 3.719 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.157003e-04 | 3.666 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.134152e-04 | 3.671 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.134152e-04 | 3.671 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.053744e-04 | 3.687 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.075695e-04 | 3.683 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.157003e-04 | 3.666 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.315479e-04 | 3.635 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.386225e-04 | 3.622 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.432244e-04 | 3.614 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.514426e-04 | 3.600 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.702910e-04 | 3.568 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.340148e-04 | 3.476 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.543654e-04 | 3.451 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.543654e-04 | 3.451 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.544709e-04 | 3.450 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.101773e-04 | 3.387 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.468973e-04 | 3.350 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.504388e-04 | 3.346 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.889702e-04 | 3.311 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.035843e-04 | 3.298 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.077387e-04 | 3.294 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.162738e-04 | 3.287 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.179281e-04 | 3.286 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.290694e-04 | 3.276 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.398251e-04 | 3.268 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.240106e-04 | 3.205 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.240106e-04 | 3.205 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.740195e-04 | 3.241 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.771876e-04 | 3.239 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.981422e-04 | 3.223 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.540355e-04 | 3.184 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.940239e-04 | 3.159 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 7.073586e-04 | 3.150 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.260197e-04 | 3.139 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.387438e-04 | 3.132 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.592738e-04 | 3.120 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 9.046351e-04 | 3.044 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.571996e-04 | 3.067 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.117595e-04 | 3.040 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.117595e-04 | 3.040 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 9.046351e-04 | 3.044 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.533213e-04 | 3.069 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.804190e-04 | 3.055 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.435926e-04 | 3.025 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.509889e-04 | 3.022 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.947513e-04 | 3.002 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.947513e-04 | 3.002 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.990702e-04 | 3.000 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.037755e-03 | 2.984 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.042617e-03 | 2.982 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.042617e-03 | 2.982 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.238120e-03 | 2.907 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.240628e-03 | 2.906 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.249788e-03 | 2.903 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.254643e-03 | 2.901 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.273882e-03 | 2.895 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.278602e-03 | 2.893 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.333305e-03 | 2.875 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.358650e-03 | 2.867 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.403958e-03 | 2.853 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.426708e-03 | 2.846 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.740235e-03 | 2.759 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.732693e-03 | 2.761 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.740787e-03 | 2.759 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.879146e-03 | 2.726 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.913857e-03 | 2.718 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.936463e-03 | 2.713 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.988425e-03 | 2.701 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.092828e-03 | 2.679 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.094256e-03 | 2.679 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.127381e-03 | 2.672 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.217143e-03 | 2.654 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.223156e-03 | 2.653 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.385764e-03 | 2.622 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.385764e-03 | 2.622 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.387699e-03 | 2.622 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.397428e-03 | 2.620 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.397428e-03 | 2.620 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.409497e-03 | 2.618 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.589510e-03 | 2.587 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.616506e-03 | 2.582 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.805388e-03 | 2.552 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.924699e-03 | 2.534 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.035597e-03 | 2.518 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.209421e-03 | 2.494 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.209421e-03 | 2.494 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.414517e-03 | 2.467 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.556020e-03 | 2.449 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.223683e-03 | 2.492 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.580121e-03 | 2.446 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.642610e-03 | 2.439 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.661359e-03 | 2.436 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.699957e-03 | 2.432 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.923731e-03 | 2.406 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.958249e-03 | 2.402 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.223680e-03 | 2.374 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.296842e-03 | 2.367 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.296842e-03 | 2.367 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.364734e-03 | 2.360 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.383594e-03 | 2.358 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.417103e-03 | 2.355 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.444317e-03 | 2.352 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.497388e-03 | 2.347 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.904738e-03 | 2.309 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.904738e-03 | 2.309 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.979978e-03 | 2.303 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.046561e-03 | 2.297 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.152700e-03 | 2.288 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.189199e-03 | 2.285 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.290587e-03 | 2.276 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.290587e-03 | 2.276 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.558146e-03 | 2.255 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.680618e-03 | 2.175 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.215024e-03 | 2.207 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.358200e-03 | 2.197 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.834450e-03 | 2.165 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.358200e-03 | 2.197 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.358200e-03 | 2.197 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.159304e-03 | 2.210 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.863925e-03 | 2.163 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.968137e-03 | 2.157 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.370501e-03 | 2.133 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.370501e-03 | 2.133 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.661221e-03 | 2.116 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.661221e-03 | 2.116 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 7.661221e-03 | 2.116 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.661221e-03 | 2.116 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.661221e-03 | 2.116 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.661221e-03 | 2.116 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.661221e-03 | 2.116 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.661221e-03 | 2.116 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.661221e-03 | 2.116 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.661221e-03 | 2.116 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.661221e-03 | 2.116 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.661221e-03 | 2.116 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.927909e-03 | 2.101 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.957550e-03 | 2.099 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.098676e-03 | 2.092 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.459347e-03 | 2.073 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 8.696558e-03 | 2.061 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.711383e-03 | 2.060 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 8.753751e-03 | 2.058 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.182951e-03 | 2.037 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.480805e-03 | 2.023 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.487645e-03 | 2.023 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.676369e-03 | 2.014 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.000510e-02 | 2.000 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.001911e-02 | 1.999 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.001911e-02 | 1.999 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.013144e-02 | 1.994 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.020493e-02 | 1.991 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.049038e-02 | 1.979 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.247461e-02 | 1.904 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.246214e-02 | 1.904 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.189090e-02 | 1.925 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.307517e-02 | 1.884 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.250690e-02 | 1.903 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.176417e-02 | 1.929 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.132504e-02 | 1.946 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.176323e-02 | 1.929 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.145189e-02 | 1.941 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.189090e-02 | 1.925 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.106884e-02 | 1.956 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.106884e-02 | 1.956 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.312447e-02 | 1.882 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.369156e-02 | 1.864 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.369156e-02 | 1.864 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.369156e-02 | 1.864 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.397470e-02 | 1.855 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.426608e-02 | 1.846 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.440370e-02 | 1.842 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.449331e-02 | 1.839 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.545392e-02 | 1.811 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.564865e-02 | 1.806 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.573726e-02 | 1.803 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.641015e-02 | 1.785 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.686881e-02 | 1.773 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.712439e-02 | 1.766 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.717911e-02 | 1.765 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.750914e-02 | 1.757 | 1 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.777758e-02 | 1.750 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.805354e-02 | 1.743 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.822469e-02 | 1.739 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.822469e-02 | 1.739 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.822469e-02 | 1.739 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.850252e-02 | 1.733 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.916009e-02 | 1.718 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.981619e-02 | 1.703 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.982761e-02 | 1.703 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.006368e-02 | 1.698 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.060171e-02 | 1.686 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.062107e-02 | 1.686 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.066770e-02 | 1.685 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.066770e-02 | 1.685 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.066770e-02 | 1.685 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.066770e-02 | 1.685 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.090711e-02 | 1.680 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.199508e-02 | 1.658 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.238539e-02 | 1.650 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.257584e-02 | 1.646 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.260535e-02 | 1.646 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.275902e-02 | 1.643 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.284072e-02 | 1.641 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.296076e-02 | 1.639 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.303813e-02 | 1.638 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.323551e-02 | 1.634 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.473220e-02 | 1.607 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.826153e-02 | 1.549 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.826153e-02 | 1.549 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.826153e-02 | 1.549 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.622904e-02 | 1.581 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.622904e-02 | 1.581 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.948873e-02 | 1.530 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.594857e-02 | 1.586 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.700000e-02 | 1.569 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.463411e-02 | 1.608 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.883641e-02 | 1.540 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.710194e-02 | 1.567 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.702507e-02 | 1.568 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.700000e-02 | 1.569 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.883641e-02 | 1.540 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.826153e-02 | 1.549 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.683219e-02 | 1.571 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.765407e-02 | 1.558 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.899363e-02 | 1.538 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.473220e-02 | 1.607 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.524355e-02 | 1.598 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.704237e-02 | 1.568 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.841582e-02 | 1.546 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.247743e-02 | 1.488 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.247743e-02 | 1.488 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.309475e-02 | 1.480 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.309475e-02 | 1.480 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.309475e-02 | 1.480 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.473697e-02 | 1.459 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.477656e-02 | 1.459 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.477994e-02 | 1.459 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.612612e-02 | 1.442 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.612612e-02 | 1.442 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.662513e-02 | 1.436 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.688309e-02 | 1.433 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.928545e-02 | 1.406 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.942286e-02 | 1.404 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.942286e-02 | 1.404 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.992205e-02 | 1.399 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.088215e-02 | 1.388 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.088215e-02 | 1.388 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.105992e-02 | 1.387 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.108644e-02 | 1.386 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.148872e-02 | 1.382 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.213557e-02 | 1.375 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.213557e-02 | 1.375 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.215599e-02 | 1.375 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.215599e-02 | 1.375 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.215599e-02 | 1.375 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.216086e-02 | 1.375 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.260263e-02 | 1.371 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.342484e-02 | 1.362 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.416709e-02 | 1.355 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.418316e-02 | 1.355 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.515911e-02 | 1.345 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.601128e-02 | 1.337 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.632424e-02 | 1.334 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.669217e-02 | 1.331 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.739776e-02 | 1.324 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.800261e-02 | 1.319 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.811285e-02 | 1.318 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.938385e-02 | 1.306 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.025113e-02 | 1.220 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 6.025113e-02 | 1.220 | 1 | 1 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 6.025113e-02 | 1.220 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.331915e-02 | 1.198 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.040547e-02 | 1.298 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.953519e-02 | 1.225 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.953519e-02 | 1.225 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.189554e-02 | 1.208 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.398744e-02 | 1.268 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.234740e-02 | 1.205 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.101129e-02 | 1.292 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.379904e-02 | 1.195 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.331915e-02 | 1.198 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.055969e-02 | 1.218 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.055969e-02 | 1.218 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.706084e-02 | 1.174 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.362497e-02 | 1.271 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.362497e-02 | 1.271 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.679360e-02 | 1.175 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.345238e-02 | 1.198 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.953519e-02 | 1.225 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.030166e-02 | 1.220 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.651164e-02 | 1.177 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.189554e-02 | 1.208 | 1 | 0 |
| DNA Repair | R-HSA-73894 | 5.419852e-02 | 1.266 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.025113e-02 | 1.220 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.104205e-02 | 1.214 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.331915e-02 | 1.198 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.338130e-02 | 1.198 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.600836e-02 | 1.252 | 1 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.216518e-02 | 1.206 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.953519e-02 | 1.225 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.553342e-02 | 1.184 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.707881e-02 | 1.244 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.770213e-02 | 1.169 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.898878e-02 | 1.161 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.898878e-02 | 1.161 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.898878e-02 | 1.161 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.954103e-02 | 1.158 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.954329e-02 | 1.158 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.954329e-02 | 1.158 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.230711e-02 | 1.141 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.296830e-02 | 1.137 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.426832e-02 | 1.129 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.548124e-02 | 1.122 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.609705e-02 | 1.119 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.609705e-02 | 1.119 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.609705e-02 | 1.119 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.658287e-02 | 1.116 | 1 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.805295e-02 | 1.108 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.805295e-02 | 1.108 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.805295e-02 | 1.108 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.875594e-02 | 1.104 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.011136e-02 | 1.096 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.011136e-02 | 1.096 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.011136e-02 | 1.096 | 1 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.014961e-02 | 1.096 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.014961e-02 | 1.096 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.041966e-02 | 1.095 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.041966e-02 | 1.095 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.131101e-02 | 1.090 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.559850e-02 | 1.068 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.561404e-02 | 1.067 | 1 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.693010e-02 | 1.061 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.775705e-02 | 1.057 | 1 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.786529e-02 | 1.056 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 8.836843e-02 | 1.054 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 8.836843e-02 | 1.054 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 8.836843e-02 | 1.054 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 8.836843e-02 | 1.054 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 8.836843e-02 | 1.054 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.003140e-02 | 1.046 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 9.019012e-02 | 1.045 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.019012e-02 | 1.045 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.164973e-02 | 1.038 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.183860e-02 | 1.037 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.214651e-02 | 1.036 | 1 | 1 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.286851e-02 | 1.032 | 1 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.304924e-02 | 1.031 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.408023e-02 | 1.027 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.408023e-02 | 1.027 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.408023e-02 | 1.027 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.435358e-02 | 1.025 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.540458e-02 | 1.020 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.570024e-02 | 1.019 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.623587e-02 | 1.017 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 9.688088e-02 | 1.014 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 9.688088e-02 | 1.014 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 9.688088e-02 | 1.014 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.804917e-02 | 1.009 | 1 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.977126e-02 | 1.001 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.001968e-01 | 0.999 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.008800e-01 | 0.996 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.040950e-01 | 0.983 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.045904e-01 | 0.981 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.046990e-01 | 0.980 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.046990e-01 | 0.980 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.046990e-01 | 0.980 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.051590e-01 | 0.978 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 1.051590e-01 | 0.978 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.195143e-01 | 0.923 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.195143e-01 | 0.923 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.195143e-01 | 0.923 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.528707e-01 | 0.816 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.528707e-01 | 0.816 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.528707e-01 | 0.816 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.528707e-01 | 0.816 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.528707e-01 | 0.816 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.392486e-01 | 0.856 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.392486e-01 | 0.856 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.392486e-01 | 0.856 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.392486e-01 | 0.856 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.384637e-01 | 0.859 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.180459e-01 | 0.928 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.321503e-01 | 0.879 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.122041e-01 | 0.950 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.122041e-01 | 0.950 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.469706e-01 | 0.833 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.469706e-01 | 0.833 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.157749e-01 | 0.936 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.497725e-01 | 0.825 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.497725e-01 | 0.825 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.497725e-01 | 0.825 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.378602e-01 | 0.861 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.551610e-01 | 0.809 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.065524e-01 | 0.972 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.392486e-01 | 0.856 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.392486e-01 | 0.856 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.419505e-01 | 0.848 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.497725e-01 | 0.825 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.392486e-01 | 0.856 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.195143e-01 | 0.923 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.075774e-01 | 0.968 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.478097e-01 | 0.830 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.478097e-01 | 0.830 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.075774e-01 | 0.968 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.180459e-01 | 0.928 | 1 | 1 |
| PCP/CE pathway | R-HSA-4086400 | 1.505042e-01 | 0.822 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.378602e-01 | 0.861 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.524521e-01 | 0.817 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.528707e-01 | 0.816 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.173438e-01 | 0.931 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.586807e-01 | 0.799 | 1 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.457176e-01 | 0.836 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.247016e-01 | 0.904 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.586807e-01 | 0.799 | 1 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.371333e-01 | 0.863 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.384637e-01 | 0.859 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.195143e-01 | 0.923 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.195143e-01 | 0.923 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.528707e-01 | 0.816 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.173438e-01 | 0.931 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.213181e-01 | 0.916 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.156295e-01 | 0.937 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.559615e-01 | 0.807 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.595490e-01 | 0.797 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.555777e-01 | 0.808 | 1 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.496182e-01 | 0.825 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.528707e-01 | 0.816 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.321503e-01 | 0.879 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.180459e-01 | 0.928 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.167742e-01 | 0.933 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.213181e-01 | 0.916 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.378602e-01 | 0.861 | 1 | 1 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.146579e-01 | 0.941 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.311287e-01 | 0.882 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.321503e-01 | 0.879 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.606499e-01 | 0.794 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.606499e-01 | 0.794 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.647616e-01 | 0.783 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.647616e-01 | 0.783 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.656201e-01 | 0.781 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.689830e-01 | 0.772 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.703217e-01 | 0.769 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.717109e-01 | 0.765 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.730249e-01 | 0.762 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.738952e-01 | 0.760 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.738952e-01 | 0.760 | 1 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.753777e-01 | 0.756 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.753777e-01 | 0.756 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.764020e-01 | 0.753 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.775509e-01 | 0.751 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.793144e-01 | 0.746 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.793144e-01 | 0.746 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.793144e-01 | 0.746 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.793144e-01 | 0.746 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.793144e-01 | 0.746 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.793144e-01 | 0.746 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.793144e-01 | 0.746 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.793144e-01 | 0.746 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.811530e-01 | 0.742 | 1 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.821261e-01 | 0.740 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.839032e-01 | 0.735 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.839032e-01 | 0.735 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.865938e-01 | 0.729 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.874941e-01 | 0.727 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.874941e-01 | 0.727 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.874941e-01 | 0.727 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.877468e-01 | 0.726 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.877468e-01 | 0.726 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.877468e-01 | 0.726 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.877468e-01 | 0.726 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.877468e-01 | 0.726 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.884768e-01 | 0.725 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.921668e-01 | 0.716 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.949675e-01 | 0.710 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.949675e-01 | 0.710 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.949675e-01 | 0.710 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.952501e-01 | 0.709 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.966013e-01 | 0.706 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.966013e-01 | 0.706 | 1 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.983729e-01 | 0.703 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.009528e-01 | 0.697 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.058514e-01 | 0.686 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.067452e-01 | 0.685 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.072209e-01 | 0.684 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.116442e-01 | 0.674 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.116442e-01 | 0.674 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.116442e-01 | 0.674 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 2.124432e-01 | 0.673 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.124432e-01 | 0.673 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.151266e-01 | 0.667 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.151895e-01 | 0.667 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.151895e-01 | 0.667 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.235617e-01 | 0.651 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.235617e-01 | 0.651 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.565338e-01 | 0.591 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.565338e-01 | 0.591 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.565338e-01 | 0.591 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.565338e-01 | 0.591 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.565338e-01 | 0.591 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.565338e-01 | 0.591 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.565338e-01 | 0.591 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.264917e-01 | 0.486 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.264917e-01 | 0.486 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.264917e-01 | 0.486 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.264917e-01 | 0.486 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.264917e-01 | 0.486 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.598307e-01 | 0.585 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.598307e-01 | 0.585 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.598307e-01 | 0.585 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.598307e-01 | 0.585 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.898705e-01 | 0.409 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.898705e-01 | 0.409 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 3.898705e-01 | 0.409 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.898705e-01 | 0.409 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.961514e-01 | 0.528 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.961514e-01 | 0.528 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.961514e-01 | 0.528 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.635759e-01 | 0.579 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.321934e-01 | 0.479 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.321934e-01 | 0.479 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.321934e-01 | 0.479 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.321934e-01 | 0.479 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.472886e-01 | 0.349 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.472886e-01 | 0.349 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.472886e-01 | 0.349 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.472886e-01 | 0.349 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.472886e-01 | 0.349 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.472886e-01 | 0.349 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.359509e-01 | 0.627 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.901162e-01 | 0.537 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.901162e-01 | 0.537 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.571596e-01 | 0.590 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.571596e-01 | 0.590 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.676877e-01 | 0.435 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.676877e-01 | 0.435 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.168317e-01 | 0.499 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.787254e-01 | 0.555 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.481488e-01 | 0.605 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.481488e-01 | 0.605 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.665483e-01 | 0.574 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.005605e-01 | 0.522 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.024184e-01 | 0.395 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.546419e-01 | 0.594 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.702396e-01 | 0.432 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.702396e-01 | 0.432 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.702396e-01 | 0.432 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.041589e-01 | 0.517 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.459079e-01 | 0.609 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.447055e-01 | 0.463 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.447055e-01 | 0.463 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.362151e-01 | 0.360 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.362151e-01 | 0.360 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.594747e-01 | 0.586 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.966900e-01 | 0.402 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.668586e-01 | 0.436 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.216979e-01 | 0.493 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.034880e-01 | 0.518 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.872456e-01 | 0.542 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.354768e-01 | 0.628 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.014046e-01 | 0.521 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.889685e-01 | 0.410 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.889685e-01 | 0.410 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.228309e-01 | 0.374 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.561690e-01 | 0.448 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.561690e-01 | 0.448 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.561690e-01 | 0.448 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.811109e-01 | 0.419 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.109685e-01 | 0.386 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.109685e-01 | 0.386 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.109685e-01 | 0.386 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.082840e-01 | 0.511 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.390970e-01 | 0.470 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.908709e-01 | 0.408 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.255259e-01 | 0.371 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.736415e-01 | 0.428 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.289357e-01 | 0.640 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.373636e-01 | 0.625 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.359509e-01 | 0.627 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.473196e-01 | 0.607 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.043909e-01 | 0.517 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.571596e-01 | 0.590 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.966900e-01 | 0.402 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.082209e-01 | 0.389 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.676877e-01 | 0.435 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.966900e-01 | 0.402 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.664615e-01 | 0.436 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.830335e-01 | 0.417 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.190094e-01 | 0.496 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.676877e-01 | 0.435 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.676877e-01 | 0.435 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.787254e-01 | 0.555 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.004132e-01 | 0.397 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.957858e-01 | 0.529 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.901162e-01 | 0.537 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.041589e-01 | 0.517 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.005605e-01 | 0.522 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.046407e-01 | 0.516 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.625077e-01 | 0.581 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.625077e-01 | 0.581 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.880091e-01 | 0.411 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.297766e-01 | 0.367 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.109685e-01 | 0.386 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.321934e-01 | 0.479 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.435820e-01 | 0.464 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.362151e-01 | 0.360 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.966900e-01 | 0.402 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.735089e-01 | 0.428 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.384966e-01 | 0.623 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.957858e-01 | 0.529 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.665483e-01 | 0.574 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.729556e-01 | 0.564 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.729556e-01 | 0.564 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.665483e-01 | 0.574 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.910025e-01 | 0.536 | 1 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.635759e-01 | 0.579 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.024184e-01 | 0.395 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.807744e-01 | 0.552 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 2.961514e-01 | 0.528 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.424858e-01 | 0.465 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.435820e-01 | 0.464 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.613238e-01 | 0.442 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.665483e-01 | 0.574 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.435820e-01 | 0.464 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.004132e-01 | 0.397 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.561690e-01 | 0.448 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.980242e-01 | 0.400 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.005605e-01 | 0.522 | 0 | 0 |
| Translation | R-HSA-72766 | 3.700364e-01 | 0.432 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.203557e-01 | 0.376 | 1 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.512508e-01 | 0.454 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.694350e-01 | 0.570 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.565338e-01 | 0.591 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.565338e-01 | 0.591 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.264917e-01 | 0.486 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.264917e-01 | 0.486 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.264917e-01 | 0.486 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.898705e-01 | 0.409 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.321934e-01 | 0.479 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.472886e-01 | 0.349 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.472886e-01 | 0.349 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.901162e-01 | 0.537 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.024184e-01 | 0.395 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.459079e-01 | 0.609 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.908709e-01 | 0.408 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.621631e-01 | 0.441 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.456877e-01 | 0.351 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.209046e-01 | 0.494 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.327969e-01 | 0.364 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.046407e-01 | 0.516 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.617861e-01 | 0.442 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.321934e-01 | 0.479 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.676877e-01 | 0.435 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.387730e-01 | 0.358 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.931360e-01 | 0.405 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.821264e-01 | 0.418 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.723047e-01 | 0.429 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.168317e-01 | 0.499 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.321934e-01 | 0.479 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.321934e-01 | 0.479 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.359509e-01 | 0.627 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.901162e-01 | 0.537 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.571596e-01 | 0.590 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.005605e-01 | 0.522 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 3.435820e-01 | 0.464 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.362151e-01 | 0.360 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.143069e-01 | 0.383 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.580029e-01 | 0.588 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.598307e-01 | 0.585 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.196480e-01 | 0.377 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.359509e-01 | 0.627 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.447055e-01 | 0.463 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.424858e-01 | 0.465 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.908709e-01 | 0.408 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.591774e-01 | 0.586 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.172849e-01 | 0.499 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.360765e-01 | 0.627 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.565338e-01 | 0.591 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.373636e-01 | 0.625 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.321934e-01 | 0.479 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.321934e-01 | 0.479 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.901162e-01 | 0.537 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.676877e-01 | 0.435 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.676877e-01 | 0.435 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.732615e-01 | 0.563 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.424858e-01 | 0.465 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.358540e-01 | 0.627 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.617861e-01 | 0.442 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.109685e-01 | 0.386 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.580029e-01 | 0.588 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.481488e-01 | 0.605 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.664615e-01 | 0.436 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.694181e-01 | 0.570 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.965463e-01 | 0.528 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.190094e-01 | 0.496 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.712175e-01 | 0.567 | 1 | 0 |
| Histamine receptors | R-HSA-390650 | 3.898705e-01 | 0.409 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.024184e-01 | 0.395 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.729556e-01 | 0.564 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.424858e-01 | 0.465 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.287365e-01 | 0.483 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.966900e-01 | 0.402 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.812604e-01 | 0.551 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.225807e-01 | 0.491 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.190094e-01 | 0.496 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 3.898705e-01 | 0.409 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.676877e-01 | 0.435 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.787254e-01 | 0.555 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.388865e-01 | 0.470 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.702396e-01 | 0.432 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.481488e-01 | 0.605 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.910025e-01 | 0.536 | 1 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.353810e-01 | 0.361 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.264917e-01 | 0.486 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.635759e-01 | 0.579 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.321934e-01 | 0.479 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.901162e-01 | 0.537 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.702396e-01 | 0.432 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.455817e-01 | 0.351 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.668586e-01 | 0.436 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.595005e-01 | 0.444 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.162619e-01 | 0.381 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.024184e-01 | 0.395 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.223128e-01 | 0.492 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.225807e-01 | 0.491 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.889685e-01 | 0.410 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.354768e-01 | 0.628 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.360471e-01 | 0.360 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.966900e-01 | 0.402 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.072725e-01 | 0.390 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.982703e-01 | 0.525 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.868457e-01 | 0.542 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 3.966900e-01 | 0.402 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.622976e-01 | 0.335 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.689461e-01 | 0.329 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.689461e-01 | 0.329 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.689461e-01 | 0.329 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.689461e-01 | 0.329 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.689461e-01 | 0.329 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.689461e-01 | 0.329 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.689461e-01 | 0.329 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.689461e-01 | 0.329 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.689461e-01 | 0.329 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.732783e-01 | 0.325 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.738358e-01 | 0.324 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.738358e-01 | 0.324 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.738358e-01 | 0.324 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.757174e-01 | 0.323 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.765380e-01 | 0.322 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.765380e-01 | 0.322 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.765380e-01 | 0.322 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.769327e-01 | 0.322 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.883503e-01 | 0.311 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.924354e-01 | 0.308 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.936962e-01 | 0.307 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.951067e-01 | 0.305 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.951067e-01 | 0.305 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.951067e-01 | 0.305 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.951067e-01 | 0.305 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.967113e-01 | 0.304 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.967113e-01 | 0.304 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.967113e-01 | 0.304 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.985538e-01 | 0.302 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 4.993062e-01 | 0.302 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.993062e-01 | 0.302 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.993062e-01 | 0.302 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.993062e-01 | 0.302 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.993062e-01 | 0.302 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.993062e-01 | 0.302 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.993062e-01 | 0.302 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.993062e-01 | 0.302 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.993062e-01 | 0.302 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.993062e-01 | 0.302 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.993062e-01 | 0.302 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.993062e-01 | 0.302 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.005127e-01 | 0.301 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.005127e-01 | 0.301 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.005127e-01 | 0.301 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.005127e-01 | 0.301 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.005127e-01 | 0.301 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.020464e-01 | 0.299 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 5.068001e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.077957e-01 | 0.294 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.077957e-01 | 0.294 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.077957e-01 | 0.294 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.077957e-01 | 0.294 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.077957e-01 | 0.294 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.119419e-01 | 0.291 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.126258e-01 | 0.290 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.134235e-01 | 0.290 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.134235e-01 | 0.290 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.226691e-01 | 0.282 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.226691e-01 | 0.282 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.229950e-01 | 0.282 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.308442e-01 | 0.275 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.308442e-01 | 0.275 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.308442e-01 | 0.275 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.308442e-01 | 0.275 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.308442e-01 | 0.275 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.308442e-01 | 0.275 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.308442e-01 | 0.275 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.314595e-01 | 0.275 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 5.338950e-01 | 0.273 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.375583e-01 | 0.270 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.375583e-01 | 0.270 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.375583e-01 | 0.270 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.375583e-01 | 0.270 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.375583e-01 | 0.270 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.380155e-01 | 0.269 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.429831e-01 | 0.265 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.435227e-01 | 0.265 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.461341e-01 | 0.263 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.461341e-01 | 0.263 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.461341e-01 | 0.263 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.461341e-01 | 0.263 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.464311e-01 | 0.262 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.464311e-01 | 0.262 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.464311e-01 | 0.262 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.464311e-01 | 0.262 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.464311e-01 | 0.262 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.464311e-01 | 0.262 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.464311e-01 | 0.262 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.464311e-01 | 0.262 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.464311e-01 | 0.262 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.464311e-01 | 0.262 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.464311e-01 | 0.262 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.464311e-01 | 0.262 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.464311e-01 | 0.262 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.464311e-01 | 0.262 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.464311e-01 | 0.262 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.464311e-01 | 0.262 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.464311e-01 | 0.262 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.464311e-01 | 0.262 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.464311e-01 | 0.262 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.464311e-01 | 0.262 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.464311e-01 | 0.262 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.464311e-01 | 0.262 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.467868e-01 | 0.262 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.483797e-01 | 0.261 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.491888e-01 | 0.260 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.527798e-01 | 0.257 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.528408e-01 | 0.257 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.589413e-01 | 0.253 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.598935e-01 | 0.252 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.598935e-01 | 0.252 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.598935e-01 | 0.252 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.598935e-01 | 0.252 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.598935e-01 | 0.252 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.598935e-01 | 0.252 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.598935e-01 | 0.252 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.615330e-01 | 0.251 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.674558e-01 | 0.246 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.693591e-01 | 0.245 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 5.765133e-01 | 0.239 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.766609e-01 | 0.239 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.766609e-01 | 0.239 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.766609e-01 | 0.239 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.766609e-01 | 0.239 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.836367e-01 | 0.234 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.836367e-01 | 0.234 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.861765e-01 | 0.232 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.876332e-01 | 0.231 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.876332e-01 | 0.231 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.876332e-01 | 0.231 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.876332e-01 | 0.231 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.876332e-01 | 0.231 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.876332e-01 | 0.231 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.876332e-01 | 0.231 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.876332e-01 | 0.231 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.891232e-01 | 0.230 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.891232e-01 | 0.230 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.891232e-01 | 0.230 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.891232e-01 | 0.230 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.891232e-01 | 0.230 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.891232e-01 | 0.230 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.891232e-01 | 0.230 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 5.891232e-01 | 0.230 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.891232e-01 | 0.230 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.891232e-01 | 0.230 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.891232e-01 | 0.230 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.891232e-01 | 0.230 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.891232e-01 | 0.230 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.891232e-01 | 0.230 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.891232e-01 | 0.230 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.909660e-01 | 0.228 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.909660e-01 | 0.228 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.921500e-01 | 0.228 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.938670e-01 | 0.226 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.954910e-01 | 0.225 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.954910e-01 | 0.225 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.003163e-01 | 0.222 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.003163e-01 | 0.222 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.051556e-01 | 0.218 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.051556e-01 | 0.218 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.068680e-01 | 0.217 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.107508e-01 | 0.214 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.122790e-01 | 0.213 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.122790e-01 | 0.213 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.122790e-01 | 0.213 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.138127e-01 | 0.212 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.138127e-01 | 0.212 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.138127e-01 | 0.212 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.140526e-01 | 0.212 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.140526e-01 | 0.212 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.140526e-01 | 0.212 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.140526e-01 | 0.212 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.140526e-01 | 0.212 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.140526e-01 | 0.212 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.140526e-01 | 0.212 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.145242e-01 | 0.211 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.166111e-01 | 0.210 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.166111e-01 | 0.210 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.166111e-01 | 0.210 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.166111e-01 | 0.210 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.166111e-01 | 0.210 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.235498e-01 | 0.205 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.277991e-01 | 0.202 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.277991e-01 | 0.202 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 6.277991e-01 | 0.202 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.277991e-01 | 0.202 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.277991e-01 | 0.202 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.277991e-01 | 0.202 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.277991e-01 | 0.202 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.277991e-01 | 0.202 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.277991e-01 | 0.202 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 6.277991e-01 | 0.202 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.277991e-01 | 0.202 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.277991e-01 | 0.202 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.277991e-01 | 0.202 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.277991e-01 | 0.202 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.277991e-01 | 0.202 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.277991e-01 | 0.202 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.277991e-01 | 0.202 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.277991e-01 | 0.202 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.277991e-01 | 0.202 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.277991e-01 | 0.202 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.277991e-01 | 0.202 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.277991e-01 | 0.202 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.277991e-01 | 0.202 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.316099e-01 | 0.200 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.325078e-01 | 0.199 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.328323e-01 | 0.199 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.382594e-01 | 0.195 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.391544e-01 | 0.194 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.391544e-01 | 0.194 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.391544e-01 | 0.194 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.391544e-01 | 0.194 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.391544e-01 | 0.194 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.391544e-01 | 0.194 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.397164e-01 | 0.194 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.397164e-01 | 0.194 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.488703e-01 | 0.188 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.500264e-01 | 0.187 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.526153e-01 | 0.185 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.526153e-01 | 0.185 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.526153e-01 | 0.185 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.526153e-01 | 0.185 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.526153e-01 | 0.185 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.580648e-01 | 0.182 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 6.624079e-01 | 0.179 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.628366e-01 | 0.179 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.628366e-01 | 0.179 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.628366e-01 | 0.179 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.628366e-01 | 0.179 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.628366e-01 | 0.179 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.628366e-01 | 0.179 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.628366e-01 | 0.179 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.628366e-01 | 0.179 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.628366e-01 | 0.179 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.628366e-01 | 0.179 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.628366e-01 | 0.179 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.628366e-01 | 0.179 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.628366e-01 | 0.179 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.628366e-01 | 0.179 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.628366e-01 | 0.179 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.628366e-01 | 0.179 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.628366e-01 | 0.179 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.628366e-01 | 0.179 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.628366e-01 | 0.179 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.628366e-01 | 0.179 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.628423e-01 | 0.179 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.629525e-01 | 0.179 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.629525e-01 | 0.179 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.629525e-01 | 0.179 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.629525e-01 | 0.179 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.655845e-01 | 0.177 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.655845e-01 | 0.177 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.716229e-01 | 0.173 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.716229e-01 | 0.173 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 6.754199e-01 | 0.170 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.777065e-01 | 0.169 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.817463e-01 | 0.166 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.817463e-01 | 0.166 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.817463e-01 | 0.166 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.817463e-01 | 0.166 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.817463e-01 | 0.166 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.817463e-01 | 0.166 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.854699e-01 | 0.164 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.854699e-01 | 0.164 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.854699e-01 | 0.164 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.854699e-01 | 0.164 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.854699e-01 | 0.164 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.854699e-01 | 0.164 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.854699e-01 | 0.164 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.854699e-01 | 0.164 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.854699e-01 | 0.164 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.854699e-01 | 0.164 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.889943e-01 | 0.162 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.898546e-01 | 0.161 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.919184e-01 | 0.160 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.945776e-01 | 0.158 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.945776e-01 | 0.158 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.945776e-01 | 0.158 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.945776e-01 | 0.158 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.945776e-01 | 0.158 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.945776e-01 | 0.158 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.945776e-01 | 0.158 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.973522e-01 | 0.157 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 6.973522e-01 | 0.157 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.030112e-01 | 0.153 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.056958e-01 | 0.151 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.056958e-01 | 0.151 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.058518e-01 | 0.151 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.067368e-01 | 0.151 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.067368e-01 | 0.151 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.067368e-01 | 0.151 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.073144e-01 | 0.150 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.119573e-01 | 0.148 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.124012e-01 | 0.147 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.124012e-01 | 0.147 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.124012e-01 | 0.147 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.124012e-01 | 0.147 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.190368e-01 | 0.143 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.215216e-01 | 0.142 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.233322e-01 | 0.141 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.233322e-01 | 0.141 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.233322e-01 | 0.141 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.233322e-01 | 0.141 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.233322e-01 | 0.141 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.233322e-01 | 0.141 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.233322e-01 | 0.141 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.233322e-01 | 0.141 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.233322e-01 | 0.141 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.233322e-01 | 0.141 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.233322e-01 | 0.141 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.240095e-01 | 0.140 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.240095e-01 | 0.140 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.267889e-01 | 0.139 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.267889e-01 | 0.139 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.267889e-01 | 0.139 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.267889e-01 | 0.139 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.267889e-01 | 0.139 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.267889e-01 | 0.139 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.268180e-01 | 0.139 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.268945e-01 | 0.139 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.268945e-01 | 0.139 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.286158e-01 | 0.138 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.361196e-01 | 0.133 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.399509e-01 | 0.131 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.408356e-01 | 0.130 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.408356e-01 | 0.130 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.443155e-01 | 0.128 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.456666e-01 | 0.127 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.456666e-01 | 0.127 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.456666e-01 | 0.127 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.456666e-01 | 0.127 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.477781e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.477781e-01 | 0.126 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.492180e-01 | 0.125 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.493812e-01 | 0.125 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.493812e-01 | 0.125 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.493812e-01 | 0.125 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.493812e-01 | 0.125 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.493812e-01 | 0.125 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.493812e-01 | 0.125 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.493812e-01 | 0.125 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.493812e-01 | 0.125 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.493812e-01 | 0.125 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.493812e-01 | 0.125 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.493812e-01 | 0.125 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.493812e-01 | 0.125 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.493812e-01 | 0.125 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.493812e-01 | 0.125 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.493812e-01 | 0.125 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.542295e-01 | 0.122 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.551517e-01 | 0.122 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 7.551517e-01 | 0.122 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.551517e-01 | 0.122 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.551517e-01 | 0.122 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.564447e-01 | 0.121 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.570020e-01 | 0.121 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.634131e-01 | 0.117 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.634131e-01 | 0.117 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.634131e-01 | 0.117 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.634131e-01 | 0.117 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.670831e-01 | 0.115 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.670831e-01 | 0.115 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.670831e-01 | 0.115 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.696279e-01 | 0.114 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.696279e-01 | 0.114 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.696279e-01 | 0.114 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.696279e-01 | 0.114 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.696279e-01 | 0.114 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.729790e-01 | 0.112 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.729790e-01 | 0.112 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.729790e-01 | 0.112 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.729790e-01 | 0.112 | 1 | 1 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.729790e-01 | 0.112 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.729790e-01 | 0.112 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.729790e-01 | 0.112 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.729790e-01 | 0.112 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.729790e-01 | 0.112 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.729790e-01 | 0.112 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.729790e-01 | 0.112 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.729790e-01 | 0.112 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.729790e-01 | 0.112 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.729790e-01 | 0.112 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.729790e-01 | 0.112 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.729790e-01 | 0.112 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.792296e-01 | 0.108 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.794048e-01 | 0.108 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.800741e-01 | 0.108 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.800741e-01 | 0.108 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.810471e-01 | 0.107 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.811609e-01 | 0.107 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.824953e-01 | 0.107 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.833970e-01 | 0.106 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.943561e-01 | 0.100 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.943561e-01 | 0.100 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.943561e-01 | 0.100 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.943561e-01 | 0.100 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.943561e-01 | 0.100 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.943561e-01 | 0.100 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.943561e-01 | 0.100 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.943561e-01 | 0.100 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.943561e-01 | 0.100 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.943561e-01 | 0.100 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.943561e-01 | 0.100 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.943561e-01 | 0.100 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.943561e-01 | 0.100 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.943561e-01 | 0.100 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.943561e-01 | 0.100 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.943561e-01 | 0.100 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.943561e-01 | 0.100 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.943561e-01 | 0.100 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.943561e-01 | 0.100 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.943561e-01 | 0.100 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.943561e-01 | 0.100 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.956966e-01 | 0.099 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.956966e-01 | 0.099 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.956966e-01 | 0.099 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.956966e-01 | 0.099 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.964783e-01 | 0.099 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.964783e-01 | 0.099 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.964783e-01 | 0.099 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.964783e-01 | 0.099 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.995582e-01 | 0.097 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.024916e-01 | 0.096 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.044431e-01 | 0.095 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.088922e-01 | 0.092 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.088922e-01 | 0.092 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.088922e-01 | 0.092 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.102754e-01 | 0.091 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.103283e-01 | 0.091 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.103283e-01 | 0.091 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.103283e-01 | 0.091 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.103283e-01 | 0.091 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.116840e-01 | 0.091 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.137214e-01 | 0.090 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.137214e-01 | 0.090 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.137214e-01 | 0.090 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.137214e-01 | 0.090 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.137214e-01 | 0.090 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.137214e-01 | 0.090 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.137214e-01 | 0.090 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.137214e-01 | 0.090 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.137214e-01 | 0.090 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.137214e-01 | 0.090 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.137214e-01 | 0.090 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.137214e-01 | 0.090 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.137214e-01 | 0.090 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.137214e-01 | 0.090 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.137214e-01 | 0.090 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.189477e-01 | 0.087 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.190283e-01 | 0.087 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.198164e-01 | 0.086 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.206604e-01 | 0.086 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.206604e-01 | 0.086 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.235788e-01 | 0.084 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.235788e-01 | 0.084 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.235788e-01 | 0.084 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.240174e-01 | 0.084 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.240174e-01 | 0.084 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.240174e-01 | 0.084 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.289671e-01 | 0.081 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.312642e-01 | 0.080 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.312642e-01 | 0.080 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.312642e-01 | 0.080 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 8.312642e-01 | 0.080 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.312642e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.312642e-01 | 0.080 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.312642e-01 | 0.080 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.312642e-01 | 0.080 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.312642e-01 | 0.080 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.312642e-01 | 0.080 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.318051e-01 | 0.080 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.318051e-01 | 0.080 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.334038e-01 | 0.079 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.368115e-01 | 0.077 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.368115e-01 | 0.077 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.368115e-01 | 0.077 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.368115e-01 | 0.077 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.368115e-01 | 0.077 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.368115e-01 | 0.077 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.368115e-01 | 0.077 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.381743e-01 | 0.077 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.423490e-01 | 0.075 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.423490e-01 | 0.075 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.423490e-01 | 0.075 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.471558e-01 | 0.072 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.471558e-01 | 0.072 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.471558e-01 | 0.072 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.471558e-01 | 0.072 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.471558e-01 | 0.072 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.471558e-01 | 0.072 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.471558e-01 | 0.072 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.471558e-01 | 0.072 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.471558e-01 | 0.072 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.471558e-01 | 0.072 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.471558e-01 | 0.072 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.471558e-01 | 0.072 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.471558e-01 | 0.072 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.471558e-01 | 0.072 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.487577e-01 | 0.071 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.487577e-01 | 0.071 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.487577e-01 | 0.071 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.508759e-01 | 0.070 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.516848e-01 | 0.070 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.523153e-01 | 0.069 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.599022e-01 | 0.066 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.599022e-01 | 0.066 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.599022e-01 | 0.066 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.599022e-01 | 0.066 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.615516e-01 | 0.065 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.615516e-01 | 0.065 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.615516e-01 | 0.065 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.615516e-01 | 0.065 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.615516e-01 | 0.065 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.615516e-01 | 0.065 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.615516e-01 | 0.065 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.615516e-01 | 0.065 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 8.615516e-01 | 0.065 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.615516e-01 | 0.065 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.615516e-01 | 0.065 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.615516e-01 | 0.065 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.615516e-01 | 0.065 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.617272e-01 | 0.065 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.617272e-01 | 0.065 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.702901e-01 | 0.060 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.702901e-01 | 0.060 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.706079e-01 | 0.060 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.706079e-01 | 0.060 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.745923e-01 | 0.058 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.745923e-01 | 0.058 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 8.745923e-01 | 0.058 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.745923e-01 | 0.058 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.745923e-01 | 0.058 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.745923e-01 | 0.058 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.745923e-01 | 0.058 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.745923e-01 | 0.058 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.745923e-01 | 0.058 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.745923e-01 | 0.058 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.745923e-01 | 0.058 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.745923e-01 | 0.058 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.758979e-01 | 0.058 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.786671e-01 | 0.056 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.789804e-01 | 0.056 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.799649e-01 | 0.056 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.831718e-01 | 0.054 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.844463e-01 | 0.053 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.850367e-01 | 0.053 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.851993e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.864053e-01 | 0.052 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.864053e-01 | 0.052 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.864053e-01 | 0.052 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.864053e-01 | 0.052 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 8.864053e-01 | 0.052 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.864053e-01 | 0.052 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.864053e-01 | 0.052 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.864053e-01 | 0.052 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.868678e-01 | 0.052 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.889688e-01 | 0.051 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.925137e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.942923e-01 | 0.049 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.942923e-01 | 0.049 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.942923e-01 | 0.049 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.942923e-01 | 0.049 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.942923e-01 | 0.049 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.966121e-01 | 0.047 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.966121e-01 | 0.047 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.966121e-01 | 0.047 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.971062e-01 | 0.047 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.971062e-01 | 0.047 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.971062e-01 | 0.047 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.971062e-01 | 0.047 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.971062e-01 | 0.047 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.971266e-01 | 0.047 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.973423e-01 | 0.047 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.973423e-01 | 0.047 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.973423e-01 | 0.047 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.051242e-01 | 0.043 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.051242e-01 | 0.043 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.054649e-01 | 0.043 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.054649e-01 | 0.043 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.054649e-01 | 0.043 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.066137e-01 | 0.043 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.067997e-01 | 0.042 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.067997e-01 | 0.042 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.067997e-01 | 0.042 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.067997e-01 | 0.042 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.067997e-01 | 0.042 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.067997e-01 | 0.042 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.067997e-01 | 0.042 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.067997e-01 | 0.042 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.086723e-01 | 0.042 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.086723e-01 | 0.042 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.123516e-01 | 0.040 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.123516e-01 | 0.040 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.123516e-01 | 0.040 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.123516e-01 | 0.040 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.123516e-01 | 0.040 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.140069e-01 | 0.039 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.142205e-01 | 0.039 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.144100e-01 | 0.039 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.144100e-01 | 0.039 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.155804e-01 | 0.038 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.155804e-01 | 0.038 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.155804e-01 | 0.038 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.155804e-01 | 0.038 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.155804e-01 | 0.038 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.155804e-01 | 0.038 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.155804e-01 | 0.038 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.155804e-01 | 0.038 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.155804e-01 | 0.038 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.155804e-01 | 0.038 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.165793e-01 | 0.038 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.190600e-01 | 0.037 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.190600e-01 | 0.037 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.190600e-01 | 0.037 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.196984e-01 | 0.036 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.197954e-01 | 0.036 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.235344e-01 | 0.035 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.235344e-01 | 0.035 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.235344e-01 | 0.035 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.235344e-01 | 0.035 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.235344e-01 | 0.035 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.235344e-01 | 0.035 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.244220e-01 | 0.034 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.244220e-01 | 0.034 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.244220e-01 | 0.034 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.247512e-01 | 0.034 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.252828e-01 | 0.034 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.266309e-01 | 0.033 | 1 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.285912e-01 | 0.032 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.288503e-01 | 0.032 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.291020e-01 | 0.032 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.302889e-01 | 0.031 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.303168e-01 | 0.031 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.307394e-01 | 0.031 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.307394e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.307394e-01 | 0.031 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.307394e-01 | 0.031 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.307394e-01 | 0.031 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.307394e-01 | 0.031 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.307394e-01 | 0.031 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.307394e-01 | 0.031 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.307394e-01 | 0.031 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.307394e-01 | 0.031 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.310521e-01 | 0.031 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.310521e-01 | 0.031 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.344158e-01 | 0.029 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.350872e-01 | 0.029 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.363981e-01 | 0.029 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.363981e-01 | 0.029 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.363981e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.372658e-01 | 0.028 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.372658e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.372658e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.372658e-01 | 0.028 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.372658e-01 | 0.028 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.376846e-01 | 0.028 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.413491e-01 | 0.026 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.416118e-01 | 0.026 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.431777e-01 | 0.025 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.431777e-01 | 0.025 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.431777e-01 | 0.025 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.431777e-01 | 0.025 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.431777e-01 | 0.025 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.431777e-01 | 0.025 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.431777e-01 | 0.025 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.431777e-01 | 0.025 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.431777e-01 | 0.025 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.432010e-01 | 0.025 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.459323e-01 | 0.024 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.459323e-01 | 0.024 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.479562e-01 | 0.023 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.485327e-01 | 0.023 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.485327e-01 | 0.023 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.485327e-01 | 0.023 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.485327e-01 | 0.023 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.501729e-01 | 0.022 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.509755e-01 | 0.022 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.520761e-01 | 0.021 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.533833e-01 | 0.021 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.533833e-01 | 0.021 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.533833e-01 | 0.021 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.533833e-01 | 0.021 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.533833e-01 | 0.021 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.533833e-01 | 0.021 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.533833e-01 | 0.021 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.533833e-01 | 0.021 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.533833e-01 | 0.021 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.540948e-01 | 0.020 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.560983e-01 | 0.019 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.571785e-01 | 0.019 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.577204e-01 | 0.019 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.577204e-01 | 0.019 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.577771e-01 | 0.019 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.577771e-01 | 0.019 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.577771e-01 | 0.019 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.577771e-01 | 0.019 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.577771e-01 | 0.019 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.579129e-01 | 0.019 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.599128e-01 | 0.018 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.602438e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.617570e-01 | 0.017 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.617570e-01 | 0.017 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.617570e-01 | 0.017 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.617570e-01 | 0.017 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.620053e-01 | 0.017 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.633512e-01 | 0.016 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.636735e-01 | 0.016 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.636735e-01 | 0.016 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.653619e-01 | 0.015 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.653619e-01 | 0.015 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.653619e-01 | 0.015 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.662672e-01 | 0.015 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.662672e-01 | 0.015 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.680145e-01 | 0.014 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.686272e-01 | 0.014 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.686272e-01 | 0.014 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.686272e-01 | 0.014 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.686272e-01 | 0.014 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.701328e-01 | 0.013 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.715849e-01 | 0.013 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.715849e-01 | 0.013 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.715849e-01 | 0.013 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.715849e-01 | 0.013 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.717615e-01 | 0.012 | 1 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.720931e-01 | 0.012 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.725312e-01 | 0.012 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.742639e-01 | 0.011 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.742639e-01 | 0.011 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.742639e-01 | 0.011 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.749937e-01 | 0.011 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.752268e-01 | 0.011 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.766905e-01 | 0.010 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.768136e-01 | 0.010 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.768394e-01 | 0.010 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.781080e-01 | 0.010 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.788884e-01 | 0.009 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.788884e-01 | 0.009 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.791051e-01 | 0.009 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.791951e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.808791e-01 | 0.008 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.808791e-01 | 0.008 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.808791e-01 | 0.008 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.826823e-01 | 0.008 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.826823e-01 | 0.008 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.826823e-01 | 0.008 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.826823e-01 | 0.008 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.826823e-01 | 0.008 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.829079e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.843155e-01 | 0.007 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.843155e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.843155e-01 | 0.007 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.848044e-01 | 0.007 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.857948e-01 | 0.006 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.857948e-01 | 0.006 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.857948e-01 | 0.006 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.871346e-01 | 0.006 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.871346e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.871346e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.871346e-01 | 0.006 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.875915e-01 | 0.005 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.880513e-01 | 0.005 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.883481e-01 | 0.005 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.883913e-01 | 0.005 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.894473e-01 | 0.005 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.894473e-01 | 0.005 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.900718e-01 | 0.004 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.903966e-01 | 0.004 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.903966e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.904428e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.904428e-01 | 0.004 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.907711e-01 | 0.004 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.907711e-01 | 0.004 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.907711e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.908216e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.908216e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.910732e-01 | 0.004 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.913444e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.921611e-01 | 0.003 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.921611e-01 | 0.003 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.921611e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.921611e-01 | 0.003 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.922822e-01 | 0.003 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.935706e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.941773e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.946805e-01 | 0.002 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.947194e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.947268e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.949777e-01 | 0.002 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.951501e-01 | 0.002 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.952244e-01 | 0.002 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.952244e-01 | 0.002 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.956752e-01 | 0.002 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.960834e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.960834e-01 | 0.002 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.961392e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.962045e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.964531e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.964531e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.964642e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.964642e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.964879e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.967526e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.967526e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.967526e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.970911e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.970911e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.970911e-01 | 0.001 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.973658e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.975159e-01 | 0.001 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.978397e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.978593e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.981653e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.983957e-01 | 0.001 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.986845e-01 | 0.001 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.986845e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.989212e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.989212e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.989415e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.989506e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.991154e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.991482e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.991990e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.992234e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.992352e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.994053e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.994053e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.994615e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.994976e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.994976e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.995178e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.996002e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.996722e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.996722e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.997120e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.997332e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.997603e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998005e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998126e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998194e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998194e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998519e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998550e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998901e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999122e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999427e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999632e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999873e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999899e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999916e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999916e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999950e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999972e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999973e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999988e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999989e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999990e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999992e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999993e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999995e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999995e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999999e-01 | 0.000 | 1 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |